@NP	Motor enrichment	1
@NP	hindlimb movement	27
@NP	spinal cord injury and glial transplantation L.D.F.	61
@NP	spinal cord injury	61
@NP	glial transplantation L.D.F.	84
@NP	Moona ,1 , ∗ , ∗ ∗ , J.L.	114
@NP	Moona ,1 , ∗	114
@NP	∗ ∗	124
@NP	J.L.	128
@NP	Leasureb ,2 , ∗ ∗ , F.H.	133
@NP	Leasureb ,2 , ∗	133
@NP	∗ , F.H.	145
@NP	∗	145
@NP	F.H.	148
@NP	Gageb and M.B.	153
@NP	Gageb	153
@NP	M.B.	163
@NP	Bungea	168
@NP	c	175
@NP	aThe Miami Project	177
@NP	Paralysis , PO Box 16960 , Mail Locator R-48 , Miami , Florida 33101 , USA Tel.	204
@NP	Paralysis	204
@NP	PO Box 16960	215
@NP	Mail Locator R-48	229
@NP	Miami	248
@NP	Florida 33101	255
@NP	USA Tel.	270
@NP	305 243 7137 , Fax	280
@NP	305 243 7137	280
@NP	Fax	294
@NP	305 243 3923 bThe Salk Institute for Biological Studies , 10010 N.	299
@NP	305 243 3923 bThe Salk Institute	299
@NP	Biological Studies , 10010 N.	336
@NP	Biological Studies	336
@NP	10010 N.	356
@NP	Torrey Pines	365
@NP	Road , La Jolla , CA 92037 , USA Tel.	378
@NP	Road	378
@NP	La Jolla	384
@NP	CA 92037	394
@NP	USA Tel.	404
@NP	+1 858 453 4100 X 1012	414
@NP	+1 858 453 4100	414
@NP	X 1012	430
@NP	Fax : +1 858 597 0824	438
@NP	Fax	438
@NP	+1 858 597 0824	443
@NP	E-mail	460
@NP	gage@salk.edu cDepartments of Cell Biology and Anatomy	468
@NP	gage@salk.edu cDepartments	468
@NP	Cell Biology and Anatomy	498
@NP	Neurological Surgery	527
@NP	University of Miami Miller School of Medicine , Miami , Florida 33101 , USA Tel.	549
@NP	University	549
@NP	Miami Miller School of Medicine , Miami , Florida 33101 , USA Tel.	563
@NP	Miami Miller School	563
@NP	Medicine , Miami , Florida 33101 , USA Tel.	586
@NP	Medicine , Miami , Florida 33101	586
@NP	USA Tel.	618
@NP	+1 305 243 4596 ; Fax : +1 305 243 3923	628
@NP	+1 305 243 4596	628
@NP	Fax : +1 305 243 3923	645
@NP	Fax	645
@NP	+1 305 243 3923	650
@NP	E-mail : mbunge@miami.edu Abstract	667
@NP	E-mail	667
@NP	mbunge@miami.edu Abstract	675
@NP	Purpose	705
@NP	This study	714
@NP	enrichment	746
@NP	hindlimb movement	766
@NP	complete spinal cord transection	794
@NP	transplantation of olfactory ensheathing glia	831
@NP	transplantation	831
@NP	olfactory ensheathing glia	850
@NP	OEG	878
@NP	a Schwann cell	900
@NP	-LRB- SC -RRB- bridge	915
@NP	SC	916
@NP	Methods	929
@NP	Motor activity	938
@NP	provision	976
@NP	motor enrichment housing	989
@NP	MEH	1015
@NP	a multi-level cage containing ramps , textured surfaces and rewards	1021
@NP	a multi-level cage	1021
@NP	ramps , textured surfaces and rewards	1051
@NP	ramps	1051
@NP	textured surfaces	1058
@NP	rewards	1080
@NP	Hindlimb joint movement	1089
@NP	22 weeks	1137
@NP	one week postsurgery	1155
@NP	rats housed in MEH to those in basic housing -LRB- BH -RRB-	1187
@NP	rats	1187
@NP	MEH	1202
@NP	those in basic housing -LRB- BH -RRB-	1209
@NP	those	1209
@NP	basic housing -LRB- BH -RRB-	1218
@NP	basic housing	1218
@NP	BH	1233
@NP	Transganglionic tracer	1238
@NP	the crushed right sciatic nerve	1279
@NP	three days	1311
@NP	sensory axons	1351
@NP	the dorsal columns	1368
@NP	immunolabeling	1407
@NP	Serotonergic axons and glial cells	1423
@NP	Serotonergic axons	1423
@NP	glial cells	1446
@NP	low affinity nerve	1469
@NP	growth factor receptor	1488
@NP	immunolabeling	1530
@NP	Results : All rats	1547
@NP	Results	1547
@NP	All rats	1556
@NP	transplants	1582
@NP	some hindlimb movement	1605
@NP	Rats housed in BH	1629
@NP	Rats	1629
@NP	BH	1644
@NP	hindlimb function	1676
@NP	hindlimb movements	1712
@NP	most rats	1749
@NP	MEH	1762
@NP	rats transplanted with SCs and OEG	1770
@NP	rats	1770
@NP	SCs and OEG	1793
@NP	effects of MEH	1806
@NP	effects	1806
@NP	MEH	1817
@NP	first significant 14 weeks	1826
@NP	14	1844
@NP	injury	1859
@NP	rats transplanted with OEG	1870
@NP	rats	1870
@NP	OEG	1893
@NP	a trend	1898
@NP	14 weeks	1920
@NP	injury	1935
@NP	this	1947
@NP	significance	1966
@NP	all rats	1983
@NP	traced sensory axons	1993
@NP	sites of transplantation	2029
@NP	sites	2029
@NP	transplantation	2038
@NP	no rat	2100
@NP	serotonergic axons observed regenerating into	2112
@NP	serotonergic axons	2112
@NP	transplants	2176
@NP	Conclusions	2190
@NP	Transection and transplantation of SC/OEG or OEG	2203
@NP	Transection and transplantation	2203
@NP	SC/OEG or OEG	2238
@NP	recovery of hindlimb function	2260
@NP	recovery	2260
@NP	hindlimb function	2272
@NP	This	2291
@NP	hindlimb movement	2306
@NP	rats housed in MEH	2341
@NP	rats	2341
@NP	MEH	2356
@NP	rats housed in BH	2390
@NP	rats	2390
@NP	BH	2405
@NP	benefits of MEH	2417
@NP	benefits	2417
@NP	MEH	2429
@NP	14 weeks	2457
@NP	injury	2472
@NP	long-term assessment of behavior	2480
@NP	long-term assessment	2480
@NP	behavior	2504
@NP	BH conditions	2529
@NP	maintenance of recovered hindlimb function	2564
@NP	maintenance	2564
@NP	recovered hindlimb function	2579
@NP	MEH	2612
@NP	studies of recovery of function following spinal cord injury	2634
@NP	studies	2634
@NP	recovery of function following spinal cord injury	2645
@NP	recovery	2645
@NP	function following spinal cord injury	2657
@NP	function	2657
@NP	spinal cord injury	2676
@NP	Introduction Successful treatment of human spinal cord injury -LRB- SCI -RRB-	2700
@NP	Introduction Successful treatment	2700
@NP	human spinal cord injury -LRB- SCI -RRB-	2737
@NP	human spinal cord injury	2737
@NP	SCI	2763
@NP	multiple interventions	2788
@NP	animal models of SCI	2815
@NP	animal models	2815
@NP	SCI	2832
@NP	combinations of therapies	2837
@NP	combinations	2837
@NP	therapies	2853
@NP	single treatments	2900
@NP	Physical activity	2925
@NP	a component of combination therapy for SCI repair	2960
@NP	a component	2960
@NP	combination therapy for SCI repair	2975
@NP	combination therapy	2975
@NP	SCI repair	2999
@NP	Evidence supporting the benefits of exercise and rehabilitation following SCI	3011
@NP	Evidence	3011
@NP	the benefits of exercise and rehabilitation following SCI	3031
@NP	the benefits	3031
@NP	exercise and rehabilitation	3047
@NP	SCI	3085
@NP	-LSB- 1 -- 8 -RSB-	3105
@NP	-LSB- 1	3105
@NP	Another promising therapeutic avenue for SCI repair	3112
@NP	Another promising therapeutic avenue	3112
@NP	SCI repair	3153
@NP	transplantation	3167
@NP	cells	3186
@NP	Schwann cells -LRB- SCs -RRB- and olfactory ensheathing glia -LRB- OEG -RRB-	3202
@NP	Schwann cells	3202
@NP	SCs	3217
@NP	olfactory ensheathing glia	3226
@NP	OEG	3254
@NP	thoracic spinal cord transection in the adult rat	3270
@NP	thoracic spinal cord transection	3270
@NP	the adult rat	3306
@NP	many CNS neurons	3321
@NP	axons	3345
@NP	grafts of purified rat or human SCs -LSB- 9 -- 13 -RSB-	3356
@NP	grafts	3356
@NP	purified rat or human SCs -LSB- 9 -- 13 -RSB-	3366
@NP	purified rat	3366
@NP	human SCs -LSB- 9 -- 13 -RSB-	3382
@NP	human SCs	3382
@NP	9 -- 13	3393
@NP	Combined transplants of SCs and OEG	3400
@NP	Combined transplants	3400
@NP	SCs and OEG	3424
@NP	axonal growth -LSB- 14 -RSB-	3452
@NP	axonal growth	3452
@NP	14 -RSB-	3467
@NP	SCs	3485
@NP	autotransplantation	3517
@NP	contusion injury -LSB- 15 -RSB-	3567
@NP	contusion injury	3567
@NP	15 -RSB-	3585
@NP	OEG with or without SC bridges	3590
@NP	OEG	3590
@NP	SC bridges	3610
@NP	CNS axon regeneration and functional recovery	3629
@NP	CNS axon regeneration	3629
@NP	functional recovery	3655
@NP	transplantation	3681
@NP	the transected thoracic spinal cord -LSB- 16	3702
@NP	the transected thoracic spinal cord	3702
@NP	16	3739
@NP	19 -RSB-	3742
@NP	the study by Ram ' on-Cueto et al. -LSB- 16 -RSB-	3750
@NP	the study	3750
@NP	Ram ' on-Cueto et al. -LSB- 16 -RSB-	3763
@NP	Ram '	3763
@NP	et al. -LSB- 16	3776
@NP	et al.	3776
@NP	16	3784
@NP	functional recoverywas	3789
@NP	a climbing task	3825
@NP	intensive training and testing from three to seven months after surgery	3851
@NP	intensive training and testing	3851
@NP	three to seven months after surgery	3887
@NP	three to seven months	3887
@NP	surgery	3915
@NP	This finding	3924
@NP	long-term rehabilitation	3951
@NP	improved recovery following transection and transplantation	3985
@NP	improved recovery	3985
@NP	transection and transplantation	4013
@NP	the considerable evidence that rehabilitation improves outcome following SCI	4052
@NP	the considerable evidence	4052
@NP	rehabilitation	4083
@NP	outcome following SCI	4107
@NP	outcome	4107
@NP	SCI	4125
@NP	we	4130
@NP	cell transplantation	4142
@NP	motor activity	4168
@NP	the combined effect	4204
@NP	functional recovery	4238
@NP	many forms of motor therapy	4267
@NP	many forms	4267
@NP	motor therapy	4281
@NP	we	4337
@NP	motor enrichment housing -LRB- MEH -RRB- , an environment with opportunities	4349
@NP	motor enrichment housing -LRB- MEH -RRB-	4349
@NP	motor enrichment housing	4349
@NP	MEH	4375
@NP	an environment with opportunities	4381
@NP	an environment	4381
@NP	opportunities	4401
@NP	increased motor activity and weight bearing	4419
@NP	rats	4473
@NP	individual ability and motivation	4503
@NP	We	4538
@NP	rats inMEHwould showenhanced functional recovery in comparison to rats	4559
@NP	rats inMEHwould showenhanced functional recovery	4559
@NP	rats inMEHwould showenhanced	4559
@NP	rats	4559
@NP	comparison to rats	4611
@NP	comparison	4611
@NP	rats	4625
@NP	basic housing -LRB- BH -RRB- conditions	4653
@NP	Materials and methods 2.1 .	4688
@NP	Materials and methods 2.1	4688
@NP	Materials	4688
@NP	methods 2.1	4702
@NP	Animals Experiments	4715
@NP	adult female Fischer 344 rats	4756
@NP	Harlan Sprague Dawley	4787
@NP	Indianapolis	4810
@NP	Indiana	4824
@NP	160 -- 192 g , approximately 3 months of age	4842
@NP	160	4842
@NP	192 g , approximately 3 months of age	4846
@NP	192 g	4846
@NP	approximately 3 months of age	4853
@NP	approximately 3 months	4853
@NP	age	4879
@NP	surgery	4893
@NP	all rats	4902
@NP	pairs in standard plexiglas housing -LRB- described below -RRB-	4924
@NP	pairs in standard plexiglas housing	4924
@NP	pairs	4924
@NP	standard plexiglas housing	4933
@NP	food and water ad libitum	4983
@NP	Rats	5010
@NP	a 12 h : 12 h light : dark cycle	5030
@NP	a 12 h	5030
@NP	12 h light	5037
@NP	dark cycle	5048
@NP	Approval	5060
@NP	the University of Miami Animal Care and Use Committee	5087
@NP	the University	5087
@NP	Miami Animal Care and Use Committee	5105
@NP	2.2	5142
@NP	Preparation of SC bridges Schwann cells	5147
@NP	Preparation	5147
@NP	SC bridges Schwann cells	5162
@NP	SC bridges	5162
@NP	cells	5181
@NP	95 -- 98 %	5202
@NP	95	5202
@NP	98 %	5205
@NP	sciatic nerves	5215
@NP	methods described previously -LSB- 20 -RSB-	5243
@NP	methods	5243
@NP	20 -RSB-	5273
@NP	segments of sciatic nerve from donor adult female Fischer rats	5287
@NP	segments	5287
@NP	sciatic nerve from donor adult female Fischer rats	5299
@NP	sciatic nerve	5299
@NP	donor adult female Fischer rats	5318
@NP	donor	5318
@NP	adult female Fischer rats	5324
@NP	perineurium	5367
@NP	plastic	5395
@NP	outgrowth of fibroblasts	5412
@NP	outgrowth	5412
@NP	fibroblasts	5425
@NP	Nerves	5438
@NP	Dulbecco 's	5495
@NP	Eagle 's Medium -LRB- DMEM , Invitrogen , Carlsbad , CA -RRB-	5515
@NP	Eagle 's Medium	5515
@NP	Eagle 's	5515
@NP	DMEM	5531
@NP	Invitrogen	5537
@NP	Carlsbad , CA	5549
@NP	fetal calf serum	5574
@NP	FCS	5592
@NP	10 %	5597
@NP	bovine pituitary extract	5603
@NP	20 μg/ml	5629
@NP	Invitrogen	5639
@NP	forskolin -LRB- 0.8 μg/ml , Sigma	5652
@NP	forskolin	5652
@NP	0.8 μg/ml	5663
@NP	Sigma	5674
@NP	Louis , MO -RRB-	5685
@NP	Louis	5685
@NP	heregulin -LRB- 2.5 nM , Genentech , San Francisco , CA -RRB-	5700
@NP	heregulin	5700
@NP	2.5 nM , Genentech , San Francisco , CA	5711
@NP	2.5 nM	5711
@NP	Genentech	5719
@NP	San Francisco	5730
@NP	CA	5745
@NP	Fibroblasts expressing Thy1 .1	5750
@NP	Fibroblasts	5750
@NP	Thy1 .1	5773
@NP	immunopanning	5802
@NP	confluency	5840
@NP	three times	5851
@NP	1.83 million SCs	5864
@NP	8.37 μl transplant medium	5902
@NP	DMEM/F12 containing 0.1 % gentamycin , Invitrogen	5929
@NP	DMEM/F12	5929
@NP	0.1 % gentamycin , Invitrogen	5949
@NP	0.1 % gentamycin	5949
@NP	Invitrogen	5966
@NP	8.33 μl human plasma fibrinogen stock	5992
@NP	8.33 μl	5992
@NP	human plasma fibrinogen stock	6000
@NP	100 mg/ml in transplant medium , Sigma	6031
@NP	100 mg/ml	6031
@NP	transplant medium , Sigma	6044
@NP	transplant medium	6044
@NP	Sigma	6063
@NP	0.42 ul gentamycin stock -LRB- 50 mg/ml , Sigma -RRB-	6071
@NP	0.42 ul gentamycin stock	6071
@NP	50 mg/ml	6097
@NP	Sigma	6107
@NP	ul calcium chloride stock -LRB- 8 % in distilled water -RRB-	6120
@NP	ul calcium chloride stock	6120
@NP	8 % in distilled water	6147
@NP	8 %	6147
@NP	distilled water	6153
@NP	0.42 ul	6174
@NP	bovine plasma aprotinin stock	6182
@NP	78 IU per 62 μl transplant medium , Sigma	6213
@NP	78 IU	6213
@NP	62 μl transplant medium , Sigma	6223
@NP	62 μl transplant medium	6223
@NP	Sigma	6248
@NP	Hollow polymer PAN/PVC -LRB- polyacrylonitrile/polyvinylchloride -RRB-	6256
@NP	channels -LRB- gift from Dr.	6317
@NP	channels	6317
@NP	gift from Dr.	6327
@NP	gift	6327
@NP	Dr.	6337
@NP	Hazlett	6344
@NP	3 mm lengths	6367
@NP	1 μl	6384
@NP	bovine plasma thrombin -LRB- 25 units per μl transplant medium , Sigma -RRB-	6392
@NP	bovine plasma thrombin	6392
@NP	25 units per μl transplant medium , Sigma	6416
@NP	25 units	6416
@NP	μl transplant medium , Sigma	6429
@NP	μl transplant medium	6429
@NP	Sigma	6451
@NP	each open end	6476
@NP	The 18 μl mixture	6491
@NP	the tubes	6527
@NP	37 ◦ C for ten minutes	6560
@NP	37 ◦ C	6560
@NP	ten minutes	6569
@NP	gelling	6590
@NP	Bridges	6599
@NP	transplant medium overnight at 37 ◦ C	6625
@NP	transplant medium	6625
@NP	37 ◦ C	6656
@NP	air containing 6 % carbon dioxide	6666
@NP	air	6666
@NP	6 % carbon dioxide	6681
@NP	Bridges measuring 2 mm in length and 2.7 mm in diameter	6700
@NP	Bridges	6700
@NP	2 mm in length and 2.7 mm in diameter	6718
@NP	2 mm in length	6718
@NP	2 mm	6718
@NP	length	6726
@NP	2.7 mm in diameter	6737
@NP	2.7 mm	6737
@NP	diameter	6746
@NP	channels	6777
@NP	Leibovitz-15 medium	6791
@NP	0.1 % gentamycin -LRB- L - 15 , Invitrogen -RRB-	6822
@NP	0.1 % gentamycin	6822
@NP	L	6839
@NP	15 , Invitrogen	6842
@NP	15	6842
@NP	Invitrogen	6846
@NP	transplantation	6879
@NP	2.3	6896
@NP	Preparation of OEG Purified OEG	6901
@NP	Preparation	6901
@NP	OEG Purified OEG	6916
@NP	the nerve fiber layer of the adult rat olfactory bulb	6952
@NP	the nerve fiber layer	6952
@NP	the adult rat olfactory bulb	6977
@NP	15 -RSB-	7031
@NP	olfactory bulbs	7045
@NP	donor adult female Fischer rats	7081
@NP	donor	7081
@NP	adult female Fischer rats	7087
@NP	SCs -LRB- except without using heregulin -RRB-	7160
@NP	SCs	7160
@NP	heregulin	7186
@NP	p75	7198
@NP	nerve growth factor receptor	7203
@NP	nerve growth	7203
@NP	factor receptor	7216
@NP	expressing cells	7233
@NP	immunopanning	7267
@NP	transplantation	7303
@NP	aliquots of 400,000 OEG	7320
@NP	aliquots	7320
@NP	400,000 OEG	7332
@NP	4 μl of transplant medium -LRB- see above -RRB-	7362
@NP	4 μl	7362
@NP	transplant medium	7370
@NP	2.4	7401
@NP	Surgeries Rats	7406
@NP	one	7431
@NP	two types	7438
@NP	transection / transplantation surgery , shown schematically in Fig. 1	7451
@NP	transection / transplantation surgery	7451
@NP	transection	7451
@NP	transplantation surgery	7464
@NP	Fig. 1	7512
@NP	Rats	7520
@NP	injection of 0.9 % saline -LRB- 0.06 ml per 100 g body weight , i.p. -RRB-	7546
@NP	injection	7546
@NP	0.9 % saline -LRB- 0.06 ml per 100 g body weight , i.p. -RRB-	7559
@NP	0.9 % saline	7559
@NP	0.06 ml per 100 g body weight , i.p.	7572
@NP	0.06 ml per 100 g body weight	7572
@NP	0.06 ml	7572
@NP	100 g body weight	7584
@NP	ketamine hydrochloride -LRB- 42.8 mg/ml , Phoenix Pharmaceuticals , St.	7620
@NP	ketamine hydrochloride -LRB- 42.8 mg/ml , Phoenix Pharmaceuticals ,	7620
@NP	ketamine hydrochloride	7620
@NP	42.8 mg/ml	7644
@NP	Phoenix Pharmaceuticals	7656
@NP	Joseph , MO -RRB-	7685
@NP	Joseph	7685
@NP	xylazine hydrochloride -LRB- 8.6 mg/ml , Phoenix -RRB-	7698
@NP	xylazine hydrochloride	7698
@NP	8.6 mg/ml	7722
@NP	Phoenix	7733
@NP	acepromazine maleate -LRB- 1.4 mg/ml , Phoenix -RRB-	7746
@NP	acepromazine maleate	7746
@NP	1.4 mg/ml	7768
@NP	Phoenix	7779
@NP	The surgical area	7789
@NP	70 % ethanol and betadine	7835
@NP	Ophthalmic ointment	7861
@NP	Lacrilube	7882
@NP	Allergan Pharmaceuticals	7893
@NP	Irvine , CA	7919
@NP	the eyes	7946
@NP	A midline incision	7974
@NP	the thoracic vertebrae and skin	8008
@NP	superficial muscles	8044
@NP	Thoracic spinal cord vertebral laminae T8 to T10	8080
@NP	Thoracic spinal cord vertebral laminae T8	8080
@NP	Thoracic spinal cord	8080
@NP	vertebral laminae T8	8101
@NP	T10	8125
@NP	The dura	8143
@NP	the dorsal midline	8167
@NP	lidocaine -LRB- 1 % , Abbott Laboratories , Abbott Park , IL , USA -RRB-	8191
@NP	lidocaine	8191
@NP	1 % , Abbott Laboratories , Abbott Park , IL , USA	8202
@NP	1 %	8202
@NP	Abbott Laboratories	8206
@NP	Abbott Park	8227
@NP	IL	8240
@NP	USA	8244
@NP	15 seconds	8265
@NP	one group of rats	8280
@NP	one group	8280
@NP	rats	8293
@NP	the T10 spinal cord	8299
@NP	angled microscissors	8340
@NP	The cord	8362
@NP	a second time	8386
@NP	a segment	8414
@NP	a 2-mm gap centered in T10	8446
@NP	a 2-mm gap	8446
@NP	T10	8469
@NP	A SC bridge , prepared as described above ,	8474
@NP	A SC bridge	8474
@NP	the gap	8535
@NP	the stumps -LRB- Fig. 1A -RRB-	8553
@NP	the stumps	8553
@NP	Fig. 1A	8565
@NP	Injections of OEG	8575
@NP	Injections	8575
@NP	OEG	8589
@NP	glass micropipettes attached to a 1-μl syringe -LRB- Hamilton , Reno , NV -RRB-	8617
@NP	glass micropipettes	8617
@NP	a 1-μl syringe -LRB- Hamilton , Reno , NV -RRB-	8649
@NP	a 1-μl syringe	8649
@NP	Hamilton	8665
@NP	Reno	8674
@NP	NV	8680
@NP	a stereotaxic micromanipulator	8695
@NP	The spinal column	8727
@NP	four 0.5 μl injections of OEG suspension	8765
@NP	four 0.5 μl injections	8765
@NP	OEG suspension	8791
@NP	the cord midline , 1 mm from the end of each stump ,	8821
@NP	the cord midline	8821
@NP	1 mm from the end of each stump	8839
@NP	1 mm	8839
@NP	the end of each stump	8849
@NP	the end	8849
@NP	each stump	8860
@NP	depths of 0.5 , 1.0 , 1.25 and 1.75 mm	8875
@NP	depths	8875
@NP	0.5 , 1.0 , 1.25 and 1.75 mm	8885
@NP	0.5	8885
@NP	1.0	8890
@NP	1.25	8895
@NP	1.75 mm	8904
@NP	a total of 200,000 cells per stump	8921
@NP	a total	8921
@NP	200,000 cells per stump	8932
@NP	200,000 cells	8932
@NP	stump	8950
@NP	Two minutes	8957
@NP	reflux of cells	9002
@NP	reflux	9002
@NP	cells	9012
@NP	withdrawal of the micropipette	9021
@NP	withdrawal	9021
@NP	the micropipette	9035
@NP	A small piece of gelfoam	9053
@NP	A small piece	9053
@NP	gelfoam	9070
@NP	place above the injection site	9090
@NP	place	9090
@NP	the injection site	9102
@NP	the second group of rats	9125
@NP	the second group	9125
@NP	rats	9145
@NP	the T10 spinal cord	9151
@NP	Care	9187
@NP	all ventral and lateral tissues , including the dura	9214
@NP	all ventral and lateral tissues	9214
@NP	the dura	9257
@NP	Stumps	9267
@NP	completeness of transection	9301
@NP	completeness	9301
@NP	transection	9317
@NP	most rats	9336
@NP	they	9346
@NP	OEG	9371
@NP	the cord stumps as described above -LRB- Fig. 1B -RRB-	9394
@NP	the cord	9394
@NP	Fig. 1B	9430
@NP	AcurvedPAN/PVC roof , 4mmin length ,	9440
@NP	AcurvedPAN/PVC roof	9440
@NP	4mmin length	9461
@NP	the site of transection	9488
@NP	the site	9488
@NP	transection	9500
@NP	adherence of the overlying tissues	9536
@NP	adherence	9536
@NP	the overlying tissues	9549
@NP	Muscle layers	9587
@NP	the skin	9622
@NP	antiseptic -LRB- 3 % hydrogen peroxide -RRB-	9648
@NP	antiseptic	9648
@NP	3 % hydrogen peroxide	9660
@NP	3 %	9660
@NP	hydrogen peroxide	9663
@NP	Michel clips -LRB- Roboz , Gaithersburg , Maryland -RRB-	9699
@NP	Michel clips	9699
@NP	Roboz	9713
@NP	Gaithersburg	9720
@NP	Maryland	9734
@NP	10 days	9764
@NP	surgery	9778
@NP	Saline -LRB- 0.9 % ; 5 ml , s.c. -RRB-	9787
@NP	Saline	9787
@NP	0.9 %	9795
@NP	5 ml , s.c.	9801
@NP	5 ml	9801
@NP	s.c.	9807
@NP	dehydration	9834
@NP	the first three days following surgeries	9851
@NP	the first three days	9851
@NP	surgeries	9882
@NP	rats	9893
@NP	analgesics	9909
@NP	daily -LRB- Tylenol , 1 ml containing 160 mg/kg body weight , p.o. -RRB-	9925
@NP	daily	9925
@NP	Tylenol , 1 ml containing 160 mg/kg body weight , p.o.	9932
@NP	Tylenol	9932
@NP	1 ml containing 160 mg/kg body weight , p.o.	9941
@NP	1 ml	9941
@NP	160 mg/kg body weight , p.o.	9957
@NP	160 mg/kg body weight	9957
@NP	p.o.	9980
@NP	the first 14 days post-surgery	9991
@NP	the first 14 days	9991
@NP	rats	10023
@NP	twice daily	10042
@NP	given injections	10058
@NP	prophylactic antibiotic	10078
@NP	Cephazolin , 0.1 ml saline containing 30 mg/kg body weight , s.c.	10103
@NP	Cephazolin	10103
@NP	0.1 ml saline containing 30 mg/kg body weight , s.c.	10115
@NP	0.1 ml saline	10115
@NP	30 mg/kg body weight , s.c.	10140
@NP	30 mg/kg body weight	10140
@NP	s.c.	10162
@NP	Bladders	10169
@NP	automatic voiding	10220
@NP	Rats	10245
@NP	the event of progressive , untreatable autophagia or autotomy	10282
@NP	the event	10282
@NP	progressive , untreatable autophagia or autotomy	10295
@NP	excessive weight loss -LRB- > 20 % of pre-operative body weight -RRB-	10347
@NP	excessive weight loss	10347
@NP	> 20 % of pre-operative body weight	10370
@NP	> 20 %	10370
@NP	>	10370
@NP	pre-operative body weight	10379
@NP	2.5	10407
@NP	Post-operative housing	10412
@NP	the first seven days following surgery	10442
@NP	the first seven days	10442
@NP	surgery	10473
@NP	rats	10482
@NP	plexiglas cages placed on heating pads -LRB- 37 ◦ C -RRB- with water and food	10515
@NP	plexiglas cages	10515
@NP	heating pads -LRB- 37 ◦ C -RRB-	10541
@NP	heating pads	10541
@NP	37 ◦ C	10555
@NP	water and food	10566
@NP	cages for easy access	10595
@NP	cages	10595
@NP	easy access	10605
@NP	Absorbent bedding -LRB- Alpha-dri , Sherpherd , Watertown , TN -RRB-	10618
@NP	Absorbent bedding	10618
@NP	Alpha-dri , Sherpherd , Watertown , TN	10637
@NP	Alpha-dri	10637
@NP	Sherpherd	10648
@NP	Watertown	10658
@NP	TN	10669
@NP	cage floors	10687
@NP	Cages	10700
@NP	Rats that survived one week post-surgery -LRB- n = 38 -RRB-	10733
@NP	Rats that survived one week post-surgery	10733
@NP	Rats	10733
@NP	one week	10752
@NP	n	10775
@NP	38	10779
@NP	either basic housing -LRB- BH -RRB- or motor-enriched housing -LRB- MEH -RRB-	10810
@NP	basic housing -LRB- BH -RRB-	10817
@NP	motor-enriched housing -LRB- MEH -RRB-	10839
@NP	motor-enriched housing	10839
@NP	MEH	10863
@NP	There	10869
@NP	no differences between BH	10880
@NP	no differences	10880
@NP	BH	10903
@NP	MEH groups in BBB	10910
@NP	MEH groups	10910
@NP	BBB	10924
@NP	one week postinjury	10934
@NP	OEG -LRB- t-test , p < 0.05 -RRB- or SC/OEG rats -LRB- t-test , p < 0.05 -RRB-	10965
@NP	OEG -LRB- t-test , p < 0.05 -RRB-	10965
@NP	OEG	10965
@NP	t-test , p < 0.05	10970
@NP	t-test , p <	10970
@NP	t-test	10970
@NP	p <	10978
@NP	p	10978
@NP	<	10980
@NP	0.05	10982
@NP	SC/OEG rats -LRB- t-test , p < 0.05 -RRB-	10991
@NP	SC/OEG rats	10991
@NP	t-test , p < 0.05	11004
@NP	t-test , p <	11004
@NP	t-test	11004
@NP	p <	11012
@NP	p	11012
@NP	<	11014
@NP	0.05	11016
@NP	there	11038
@NP	no differences in locomotor performance between groups at this time	11049
@NP	no differences	11049
@NP	locomotor performance between groups at this time	11067
@NP	locomotor performance	11067
@NP	groups at this time	11097
@NP	groups	11097
@NP	this time	11107
@NP	Figure 2 -LRB- A -RRB- and Movie 1	11118
@NP	Figure 2 -LRB- A -RRB-	11118
@NP	Figure 2	11118
@NP	A	11127
@NP	Movie 1	11134
@NP	BH , namely standard plexiglas cages measuring 17 long , 8 wide and 8 high	11149
@NP	BH	11149
@NP	namely standard plexiglas cages measuring 17 long , 8 wide and 8 high	11153
@NP	namely standard plexiglas cages	11153
@NP	17	11195
@NP	The cage roof	11226
@NP	ad libitum access	11248
@NP	food and water	11269
@NP	bottles with long , curved tips	11289
@NP	bottles	11289
@NP	long , curved tips	11302
@NP	long	11302
@NP	curved tips	11308
@NP	Rats	11322
@NP	Figure 2 -LRB- B -RRB- and Movie 2	11353
@NP	Figure 2 -LRB- B -RRB-	11353
@NP	Figure 2	11353
@NP	B	11362
@NP	Movie 2	11369
@NP	MEH , a three-level	11384
@NP	MEH	11384
@NP	a three-level	11389
@NP	cage	11410
@NP	Model 140 , MidWest `` Homes for Pets '' distributed by www.theferretstore.com	11416
@NP	Model 140	11416
@NP	MidWest `` Homes for Pets '' distributed by www.theferretstore.com	11427
@NP	MidWest `` Homes for Pets ''	11427
@NP	MidWest	11427
@NP	`` Homes for Pets ''	11435
@NP	Homes	11436
@NP	Pets	11446
@NP	www.theferretstore.com	11467
@NP	The MEH set-up	11492
@NP	36	11516
@NP	a smooth plastic floor with two upper plastic shelves	11556
@NP	a smooth plastic floor	11556
@NP	two upper plastic shelves	11584
@NP	Cage walls	11611
@NP	11-gauge wire -LRB- 15/16 × 6 1/16 -RRB-	11635
@NP	11-gauge wire	11635
@NP	15/16 × 6 1/16	11650
@NP	15/16	11650
@NP	× 6 1/16	11656
@NP	This	11669
@NP	cage	11681
@NP	function	11727
@NP	rats with severe traumatic brain injury -LSB- 21 -RSB-	11739
@NP	rats	11739
@NP	severe traumatic brain injury -LSB- 21 -RSB-	11749
@NP	severe traumatic brain injury	11749
@NP	21 -RSB-	11780
@NP	the present study	11801
@NP	order	11822
@NP	an environment	11839
@NP	rats	11860
@NP	duress	11920
@NP	potential adverse effects	11937
@NP	early overuse	11966
@NP	impaired limbs	11983
@NP	recovery in several models of CNS injury	12041
@NP	recovery	12041
@NP	several models of CNS injury	12053
@NP	several models	12053
@NP	CNS injury	12071
@NP	-LSB- 22	12082
@NP	25 -RSB-	12087
@NP	addition	12096
@NP	the MEH	12106
@NP	reinforcement	12138
@NP	anymovements	12156
@NP	function	12204
@NP	hindlimb sweeping -LRB- extensive , alternating movements -RRB-	12227
@NP	hindlimb sweeping	12227
@NP	extensive , alternating movements	12246
@NP	extensive	12246
@NP	movements	12269
@NP	retropulsion , partial weight support and plantar placement	12281
@NP	retropulsion	12281
@NP	partial weight support	12295
@NP	plantar placement	12322
@NP	inter-level ramps	12366
@NP	angles of approximately 35 degrees	12396
@NP	angles	12396
@NP	approximately 35 degrees	12406
@NP	the horizontal	12437
@NP	Plastic , non-toxic toys , tunnels and a running wheel	12453
@NP	Plastic	12453
@NP	non-toxic toys	12462
@NP	tunnels	12478
@NP	a running wheel	12490
@NP	9 diameter , www.theferretstore.com	12507
@NP	9 diameter	12507
@NP	www.theferretstore.com	12522
@NP	the ground floor	12561
@NP	The running wheel	12579
@NP	two months	12615
@NP	hindlimbs	12634
@NP	use	12686
@NP	A third upper level and an inter-level ramp	12691
@NP	A third upper level	12691
@NP	an inter-level ramp	12715
@NP	both consisting of wire grid	12736
@NP	wire grid	12755
@NP	two months in an attempt	12783
@NP	two months	12783
@NP	an attempt	12797
@NP	improvements in hindpaw movements	12830
@NP	improvements	12830
@NP	hindpaw movements	12846
@NP	bedding -LRB- crumpled paper towels -RRB-	12873
@NP	bedding	12873
@NP	crumpled paper towels	12882
@NP	crumpled paper	12882
@NP	towels	12897
@NP	Froot Loops	12917
@NP	Kellogg 's	12930
@NP	the upper levels	12950
@NP	rats	12977
@NP	sticks -LRB- Hartz Mountain Corporation , Secaucus , NJ -RRB-	13000
@NP	sticks	13000
@NP	Hartz Mountain Corporation	13008
@NP	Secaucus	13036
@NP	NJ	13046
@NP	cage walls -LRB- 6 to 12 inches above the first and second levels -RRB-	13077
@NP	cage walls	13077
@NP	6 to 12 inches above the first and second levels	13089
@NP	6 to 12 inches	13089
@NP	the first and second levels	13110
@NP	climbing of wire walls	13152
@NP	climbing	13152
@NP	wire walls	13164
@NP	Food and water	13176
@NP	Food	13176
@NP	water	13185
@NP	opposite sides of the ground floor , thereby encouragingmovement	13206
@NP	opposite sides	13206
@NP	the ground floor , thereby encouragingmovement	13224
@NP	the ground floor	13224
@NP	encouragingmovement	13250
@NP	ad libitum access	13283
@NP	Rats	13302
@NP	groups of up to 12	13322
@NP	groups	13322
@NP	up to 12	13332
@NP	MEH	13342
@NP	environmental enrichment , cognitive challenge and social interactions	13376
@NP	environmental enrichment	13376
@NP	cognitive challenge	13402
@NP	social interactions	13426
@NP	a specialized environment	13456
@NP	any hindlimb movements	13518
@NP	Photographs and movies	13542
@NP	the nocturnal cycle when rats are most active	13582
@NP	the nocturnal cycle	13582
@NP	rats	13607
@NP	rats in BH	13637
@NP	rats	13637
@NP	BH	13645
@NP	the same room	13661
@NP	rats housed in MEH	13678
@NP	rats	13678
@NP	MEH	13693
@NP	all	13698
@NP	the same light , humidity and temperature conditions	13718
@NP	BH rats	13771
@NP	the rats housed in MEH	13824
@NP	the rats	13824
@NP	MEH	13843
@NP	2.6	13866
@NP	Behavioral testing Locomotion	13871
@NP	the BBB open-field test rating scale	13920
@NP	26 -RSB-	13958
@NP	two observers blind to treat ment groups	13966
@NP	two observers	13966
@NP	ment groups	13995
@NP	BBB assessment	14008
@NP	22 weeks	14048
@NP	one week following transection	14068
@NP	one week	14068
@NP	transection	14087
@NP	Only the 29 rats that survived until the end of the experiment	14110
@NP	Only the 29 rats	14110
@NP	the end of the experiment	14147
@NP	the end	14147
@NP	the experiment	14158
@NP	analysis	14191
@NP	2.7	14201
@NP	Tract	14206
@NP	the central branch of sensory axons	14229
@NP	the central branch	14229
@NP	sensory axons	14251
@NP	the right hindlimb sciatic nerve , transganglionic tracer	14270
@NP	the right hindlimb sciatic nerve	14270
@NP	transganglionic tracer	14304
@NP	the last BBB test and three days	14346
@NP	the last BBB test	14346
@NP	three days	14368
@NP	the end of the experiment	14386
@NP	the end	14386
@NP	the experiment	14397
@NP	Rats	14413
@NP	anesthetized using halothane	14423
@NP	2 %	14453
@NP	oxygen -LRB- 0.6 liters/minute -RRB-	14460
@NP	oxygen	14460
@NP	0.6 liters/minute	14468
@NP	the right hindlimb	14488
@NP	the sciatic nerve	14551
@NP	midthigh level	14584
@NP	The nerve	14600
@NP	10 seconds using forceps	14626
@NP	10 seconds	14626
@NP	forceps	14643
@NP	3 μl	14656
@NP	cholera toxin beta subunit solution	14664
@NP	1 %	14701
@NP	CTB , List Biologicals , Campbell , CA	14704
@NP	CTB	14704
@NP	List Biologicals	14709
@NP	Campbell	14727
@NP	CA	14737
@NP	the crush	14767
@NP	three minutes	14784
@NP	the needle -LRB- 32-gauge -RRB-	14799
@NP	the needle	14799
@NP	the nerve	14839
@NP	2.8	14871
@NP	Histology	14876
@NP	22 weeks post-surgery , rats	14889
@NP	22 weeks post-surgery	14889
@NP	rats	14912
@NP	100 ml phosphate	14986
@NP	saline -LRB- PBS -RRB- and then with 500 ml 4 % paraformaldehyde	15012
@NP	saline -LRB- PBS -RRB- and then with 500 ml	15012
@NP	saline -LRB- PBS -RRB-	15012
@NP	saline	15012
@NP	PBS	15020
@NP	then with 500 ml	15029
@NP	then	15029
@NP	500 ml	15039
@NP	PBS	15069
@NP	Spinal cords	15074
@NP	overnight	15111
@NP	fixative at 4 ◦ C	15124
@NP	fixative	15124
@NP	4 ◦ C	15136
@NP	three days	15172
@NP	cryoprotectant -LRB- 30 % sucrose in PBS -RRB- at 4 ◦ C.	15186
@NP	cryoprotectant -LRB- 30 % sucrose in PBS -RRB-	15186
@NP	cryoprotectant	15186
@NP	30 % sucrose in PBS	15202
@NP	30 % sucrose	15202
@NP	PBS	15217
@NP	4 ◦ C.	15225
@NP	4 ◦	15225
@NP	C.	15227
@NP	Five series of twenty-μmthick	15230
@NP	Five series	15230
@NP	twenty-μmthick	15245
@NP	horizontal 2 cm-long cryosections	15261
@NP	spinal cord	15298
@NP	the transection	15322
@NP	transplant site	15339
@NP	coated slides -LRB- Snowcoat X-tra , Surgipath , Richmond , IL -RRB-	15369
@NP	coated slides	15369
@NP	Snowcoat X-tra	15384
@NP	Surgipath , Richmond	15400
@NP	IL	15421
@NP	− 20	15444
@NP	◦ C.	15447
@NP	Immunolabeling	15451
@NP	slides	15483
@NP	low-volume , low-evaporation chambers	15496
@NP	Sequenza , Thermo Shandon , Pittsburgh , PA	15534
@NP	Sequenza	15534
@NP	Thermo Shandon	15544
@NP	Pittsburgh	15560
@NP	PA	15572
@NP	manufacturer 's instructions	15589
@NP	manufacturer 's	15589
@NP	Sections	15618
@NP	immunolabeling	15667
@NP	One series of sections	15683
@NP	One series	15683
@NP	sections	15697
@NP	CTB	15738
@NP	Sections	15743
@NP	buffer	15774
@NP	100 mM Tris-HCl	15795
@NP	150 mM NaCl -LRB- TBS -RRB- and 2 % Triton-X 100 -LRB- TXTBS -RRB-	15812
@NP	150 mM NaCl -LRB- TBS -RRB-	15812
@NP	150 mM NaCl	15812
@NP	TBS	15825
@NP	2 % Triton-X 100 -LRB- TXTBS -RRB-	15834
@NP	2 % Triton-X	15834
@NP	100 -LRB- TXTBS -RRB-	15846
@NP	Endogenous peroxidase activity	15859
@NP	sections	15917
@NP	30 minutes in 3 % hydrogen peroxide and 10 % methanol	15930
@NP	30 minutes	15930
@NP	3 % hydrogen peroxide and 10 % methanol	15944
@NP	3 % hydrogen peroxide	15944
@NP	10 % methanol	15969
@NP	Sections	15983
@NP	overnight	16016
@NP	2 % TXTBS	16032
@NP	5 % heat-treated normal rabbit serum	16052
@NP	NRS	16089
@NP	Vector Laboratories	16094
@NP	Burlingame , CA	16115
@NP	incubating	16139
@NP	60 hours in 2 % TXTBS	16154
@NP	60 hours	16154
@NP	2 % TXTBS	16166
@NP	goat-anti CTB -LRB- 1:20,000 , List Biologicals -RRB- and 5 % NRS	16186
@NP	goat-anti CTB -LRB- 1:20,000 , List Biologicals -RRB-	16186
@NP	goat-anti CTB	16186
@NP	1:20,000 , List Biologicals	16201
@NP	1:20,000	16201
@NP	List Biologicals	16211
@NP	5 % NRS	16233
@NP	Sections	16241
@NP	two hours in TBS	16285
@NP	two hours	16285
@NP	TBS	16298
@NP	rabbit anti-goat IgG -LRB- 1:200 , Vector -RRB- and 5 % NRS	16326
@NP	rabbit anti-goat IgG -LRB- 1:200 , Vector -RRB-	16326
@NP	rabbit anti-goat IgG	16326
@NP	1:200	16348
@NP	Vector	16355
@NP	5 % NRS	16367
@NP	Sections	16375
@NP	two hours in TBS	16419
@NP	two hours	16419
@NP	TBS	16432
@NP	streptavidin-horseradish peroxidase conjugate	16447
@NP	Dako	16494
@NP	Carpinteria	16500
@NP	CA	16513
@NP	Sections , washed twice in TBS and twice in 50 mM Tris-HCl -LRB- TNS -RRB- ,	16518
@NP	Sections	16518
@NP	TBS	16544
@NP	50 mM Tris-HCl -LRB- TNS -RRB-	16561
@NP	50 mM Tris-HCl	16561
@NP	TNS	16577
@NP	15 minutes in TNS	16601
@NP	15 minutes	16601
@NP	TNS	16615
@NP	0.05 % diaminobenzidine -LRB- Sigma -RRB- and 0.009 % hydrogen peroxide	16630
@NP	0.05 % diaminobenzidine	16630
@NP	Sigma	16654
@NP	0.009 % hydrogen peroxide	16665
@NP	Sections	16691
@NP	inTNSand	16711
@NP	cresyl violet staining solution	16732
@NP	87mMacetic acid	16765
@NP	5 mMsodium acetate and 13 mg cresyl violet	16792
@NP	5 mMsodium acetate	16792
@NP	13 mg cresyl violet	16815
@NP	ten minutes	16840
@NP	distilled water	16874
@NP	alcohols	16911
@NP	Sub-X -LRB- Surgipath -RRB-	16944
@NP	Sub-X	16944
@NP	Surgipath	16951
@NP	A second series of sections	16963
@NP	A second series	16963
@NP	sections	16982
@NP	immunofluorescence labeled for serotonin and p75	16995
@NP	immunofluorescence	16995
@NP	serotonin and p75	17026
@NP	Sections	17045
@NP	0.2 % TXTBS	17077
@NP	overnight	17100
@NP	0.2 % TXTBS containing 10 % heat-inactivated normal goat serum -LRB- NGS -RRB-	17116
@NP	0.2 % TXTBS	17116
@NP	10 % heat-inactivated normal goat serum	17138
@NP	NGS	17178
@NP	Sections	17184
@NP	overnight	17208
@NP	0.2 % TXTBS	17221
@NP	rabbit polyclonal antibody	17243
@NP	serotonin -LRB- 1:500 , Immunostar , Hudson , WI -RRB- and 1 % NGS	17278
@NP	serotonin -LRB- 1:500 , Immunostar , Hudson , WI -RRB-	17278
@NP	serotonin	17278
@NP	1:500	17289
@NP	Immunostar	17296
@NP	Hudson , WI	17308
@NP	1 % NGS	17324
@NP	Sections	17332
@NP	five hours in TBS	17370
@NP	five hours	17370
@NP	TBS	17384
@NP	goat anti-rabbit IgG	17399
@NP	Alexa 594 -LRB- 1:200 , Molecular Probes , Eugene , OR -RRB-	17434
@NP	Alexa 594	17434
@NP	1:200 , Molecular Probes , Eugene , OR	17445
@NP	1:200	17445
@NP	Molecular Probes	17452
@NP	Eugene	17470
@NP	OR	17478
@NP	1 % NGS	17487
@NP	Sections	17495
@NP	Sections	17539
@NP	overnight	17563
@NP	mouse monoclonal antibody	17576
@NP	p75 -LRB- 192 IgG supernatant from hybridoma cells supplied by Dr.	17610
@NP	p75 -LRB- 192 IgG supernatant from hybridoma cells	17610
@NP	p75	17610
@NP	192 IgG supernatant from hybridoma cells	17615
@NP	192 IgG supernatant	17615
@NP	hybridoma cells	17640
@NP	Dr.	17668
@NP	Eugene Johnson , Washington University , St.	17672
@NP	Eugene Johnson	17672
@NP	Washington University , St.	17688
@NP	Louis , MO -RRB- containing 5 % NGS and 0.1 % Tween-20	17715
@NP	Louis , MO -RRB-	17715
@NP	Louis	17715
@NP	5 % NGS and 0.1 % Tween-20	17737
@NP	5 % NGS	17737
@NP	0.1 % Tween-20	17748
@NP	Sections	17763
@NP	two hours in TBS	17807
@NP	two hours	17807
@NP	TBS	17820
@NP	goat anti-mouse IgG	17835
@NP	Alexa 488 -LRB- 1:200 , Molecular Probes -RRB- and bisbenzimide	17869
@NP	Alexa 488 -LRB- 1:200 , Molecular Probes -RRB-	17869
@NP	Alexa 488	17869
@NP	1:200 , Molecular Probes	17880
@NP	1:200	17880
@NP	Molecular Probes	17887
@NP	bisbenzimide	17909
@NP	Sections	17923
@NP	PBS	17947
@NP	Vectamount -LRB- Vector Laboratories -RRB-	17985
@NP	Vectamount	17985
@NP	Vector Laboratories	17997
@NP	the presence of myelinated axons	18030
@NP	the presence	18030
@NP	myelinated axons	18046
@NP	the midpoint of SC bridges	18066
@NP	the midpoint	18066
@NP	SC bridges	18082
@NP	a subset of SC/OEG rats -LRB- n = 3 -RRB-	18096
@NP	a subset	18096
@NP	SC/OEG rats -LRB- n = 3 -RRB-	18108
@NP	SC/OEG rats	18108
@NP	n	18121
@NP	3	18125
@NP	a 1-mm thick transverse slice	18129
@NP	plastic embedding	18173
@NP	use of available tissue	18204
@NP	use	18204
@NP	available tissue	18211
@NP	these specimens	18229
@NP	rats	18264
@NP	complications	18316
@NP	the end of the experiment	18339
@NP	the end	18339
@NP	the experiment	18350
@NP	these specimens	18366
@NP	myelinated axons	18413
@NP	the other histology	18443
@NP	all other histology	18485
@NP	cords	18506
@NP	rats	18536
@NP	the full study	18555
@NP	perfusion fixed under terminal anaesthesia	18579
@NP	perfusion	18579
@NP	terminal anaesthesia	18601
@NP	plastic embedding	18627
@NP	cords	18646
@NP	further	18657
@NP	immersion in glutaraldehyde and osmium tetroxide	18674
@NP	immersion	18674
@NP	glutaraldehyde and osmium tetroxide	18687
@NP	dehydration and embedding	18732
@NP	plastic	18761
@NP	Semi-thin sections -LRB- 1 μm -RRB-	18770
@NP	Semi-thin sections	18770
@NP	1 μm	18790
@NP	toluidine blue -LSB- 10 -RSB-	18814
@NP	toluidine blue -LSB-	18814
@NP	The criteria to recognize peripheral-type myelin in plastic cross sections	18835
@NP	peripheral-type myelin in plastic cross sections	18861
@NP	plastic cross	18887
@NP	the presence	18915
@NP	a signet ring configuration	18931
@NP	myelin ring with the proximate SC nucleus	18960
@NP	myelin ring	18960
@NP	the proximate SC nucleus	18977
@NP	the presence	19007
@NP	space	19023
@NP	the myelinated axons , which is caused by the formation of extracellular matrix	19037
@NP	the myelinated axons	19037
@NP	the formation of extracellular matrix	19078
@NP	the formation	19078
@NP	extracellular matrix	19095
@NP	contrast	19120
@NP	central-type myelin profiles	19130
@NP	adjacent nuclei	19174
@NP	little or no space between them	19199
@NP	little or no space	19199
@NP	them	19226
@NP	15 -RSB-	19232
@NP	Sections	19237
@NP	DEPEX -LRB- Electron Microscopy Sciences , Fort Washington , PA -RRB-	19270
@NP	DEPEX	19270
@NP	Electron Microscopy Sciences , Fort Washington , PA	19277
@NP	Electron Microscopy Sciences	19277
@NP	Fort Washington	19307
@NP	PA	19324
@NP	Axiovert	19346
@NP	Zeiss	19356
@NP	a digital camera and PC software	19369
@NP	Neurolucida	19403
@NP	Microbrightfield	19416
@NP	Williston , VT	19433
@NP	2.9	19449
@NP	Statistical analysis	19454
@NP	The surgery	19475
@NP	the OEG groups	19499
@NP	spinal cord transection	19515
@NP	that	19559
@NP	the SC/OEG groups	19567
@NP	removal	19586
@NP	a two millimeter segment	19597
@NP	spinal cord and implantation of a fibrin bridge containing SCs	19625
@NP	spinal cord and implantation	19625
@NP	a fibrin bridge containing SCs	19657
@NP	a fibrin bridge	19657
@NP	SCs	19684
@NP	the injury model	19698
@NP	a factor in these experiments	19718
@NP	a factor	19718
@NP	these experiments	19730
@NP	differences between groups in mean BBB score	19749
@NP	differences	19749
@NP	groups in mean BBB score	19769
@NP	groups	19769
@NP	mean BBB score	19779
@NP	repeated measures	19818
@NP	analysis	19836
@NP	ANOVA	19858
@NP	each injury type	19872
@NP	p = 0.05	19901
@NP	p	19901
@NP	= 0.05	19903
@NP	the time at which differences between groups first became significant	19924
@NP	the time	19924
@NP	differences between groups	19942
@NP	differences	19942
@NP	groups	19962
@NP	the last ten time points	19995
@NP	post hoc ttests	20040
@NP	significance levels	20061
@NP	Bonferroni 's correction for multiple comparisons -LRB- p < 0.005 -RRB-	20096
@NP	Bonferroni 's correction	20096
@NP	Bonferroni 's	20096
@NP	multiple comparisons -LRB- p < 0.005 -RRB-	20124
@NP	multiple comparisons	20124
@NP	p < 0.005	20146
@NP	p	20146
@NP	< 0.005	20148
@NP	<	20148
@NP	0.005	20149
@NP	Variances	20157
@NP	groups	20194
@NP	Levene 's test for equality	20209
@NP	Levene 's test	20209
@NP	Levene 's	20209
@NP	equality	20227
@NP	p <	20244
@NP	most comparisons	20257
@NP	Differences in the observed frequency of mortality between all four groups	20275
@NP	Differences	20275
@NP	the observed frequency of mortality between all four groups	20290
@NP	the observed frequency	20290
@NP	mortality between all four groups	20316
@NP	mortality	20316
@NP	all four groups	20334
@NP	Pearson 's Chi square test -LRB- p = 0.05 -RRB-	20370
@NP	Pearson 's Chi square test	20370
@NP	Pearson 's	20370
@NP	p	20397
@NP	0.05	20401
@NP	Differences	20408
@NP	the observed frequency of mortality between paired subgroups	20423
@NP	the observed frequency	20423
@NP	mortality between paired subgroups	20449
@NP	mortality	20449
@NP	paired subgroups	20467
@NP	Fisher 's exact test for 2 × 2 comparisons -LRB- p = 0.05 -RRB-	20519
@NP	Fisher 's exact test	20519
@NP	Fisher 's	20519
@NP	2 × 2 comparisons -LRB- p = 0.05 -RRB-	20543
@NP	2 × 2 comparisons	20543
@NP	p	20562
@NP	0.05	20566
@NP	Statistical analyses	20573
@NP	SPSS -LRB- SPSS Inc. , Chicago , IL -RRB-	20615
@NP	SPSS	20615
@NP	SPSS Inc.	20621
@NP	Chicago	20632
@NP	IL	20641
@NP	Results Fig. 1 .	20650
@NP	Results	20650
@NP	Fig. 1	20658
@NP	Schematic depicting the two types of surgical intervention .	20666
@NP	Schematic	20666
@NP	the two types of surgical intervention	20686
@NP	the two types	20686
@NP	surgical intervention	20703
@NP	thoracic transection of adult rat spinal cords , -LRB- A -RRB-	20736
@NP	thoracic transection	20736
@NP	adult rat spinal cords , -LRB- A -RRB-	20760
@NP	adult rat spinal cords	20760
@NP	A	20785
@NP	a gap	20788
@NP	a SC bridge	20810
@NP	injection of OEG	20841
@NP	injection	20841
@NP	OEG	20854
@NP	the stumps	20863
@NP	-LRB- B -RRB- OEG	20875
@NP	-LRB- B -RRB-	20875
@NP	OEG	20879
@NP	the stumps	20902
@NP	accompanying SC bridge implantation	20921
@NP	Fig. 2 .	20959
@NP	Fig.	20959
@NP	2	20964
@NP	Rats	20967
@NP	one of two different types of housing	21007
@NP	one	21007
@NP	two different types of housing	21014
@NP	two different types	21014
@NP	housing	21037
@NP	Digital	21046
@NP	photograph showing -LRB- A -RRB- basic and -LRB- B -RRB- motor enriched housing	21054
@NP	photograph showing -LRB- A -RRB- basic	21054
@NP	photograph showing -LRB- A -RRB-	21054
@NP	photograph showing	21054
@NP	A	21074
@NP	B	21088
@NP	motor enriched housing	21091
@NP	Fig. 3 .	21116
@NP	Fig.	21116
@NP	3	21121
@NP	field locomotor	21129
@NP	BBB	21146
@NP	testing	21151
@NP	all groups of rats	21171
@NP	all groups	21171
@NP	rats	21185
@NP	a small degree of hindlimb function	21200
@NP	a small degree	21200
@NP	hindlimb function	21218
@NP	this	21245
@NP	groups of rats housed in motor enriched environments	21273
@NP	groups	21273
@NP	rats housed in motor enriched environments	21283
@NP	rats	21283
@NP	motor enriched environments	21298
@NP	Graphs	21327
@NP	means and standard errors	21342
@NP	the mean -LRB- SEM -RRB-	21371
@NP	the mean	21371
@NP	SEM	21381
@NP	hindlimb BBB scores	21398
@NP	A	21423
@NP	all rats	21426
@NP	22 weeks	21452
@NP	postinjury , -LRB- B -RRB- all rats transplanted only with OEG	21461
@NP	postinjury	21461
@NP	B	21474
@NP	all rats transplanted only with OEG	21477
@NP	all rats	21477
@NP	OEG	21509
@NP	C	21519
@NP	all rats	21522
@NP	SCs and OEG	21549
@NP	Asterisks	21562
@NP	statistically significant differences between groups	21581
@NP	statistically significant differences	21581
@NP	groups	21627
@NP	a given time	21637
@NP	Error bars	21651
@NP	the SC/OEG/MEH group	21681
@NP	it	21705
@NP	largest number of rats	21712
@NP	largest number	21712
@NP	rats	21730
@NP	Fig. 4 .	21737
@NP	Fig.	21737
@NP	4	21742
@NP	Large numbers of peripherally myelinated axons	21745
@NP	Large numbers	21745
@NP	axons	21786
@NP	SC bridges	21808
@NP	Micrograph	21820
@NP	a region within a semi-thin transverse section	21839
@NP	a region	21839
@NP	a semi-thin transverse section	21855
@NP	a SC graft , taken from a SC/OEG rat that survived 12 weeks in MEH	21894
@NP	a SC graft	21894
@NP	a SC/OEG rat that survived 12 weeks in MEH	21917
@NP	a SC/OEG rat	21917
@NP	12 weeks	21944
@NP	MEH	21956
@NP	Panel A	21961
@NP	axons	22005
@NP	the graft	22022
@NP	Blood vessels	22033
@NP	asterisks	22065
@NP	Scale	22077
@NP	25 μm	22089
@NP	Panel B	22096
@NP	myelinated axons	22116
@NP	the box in A shown at higher magnification	22138
@NP	the box	22138
@NP	A shown at higher magnification	22149
@NP	the arrow	22185
@NP	the SC nucleus	22196
@NP	the myelin , an identifying feature of SC-formed myelin	22231
@NP	the myelin	22231
@NP	an identifying feature of SC-formed myelin	22243
@NP	an identifying feature	22243
@NP	SC-formed myelin	22269
@NP	Scale	22287
@NP	5 μm	22299
@NP	Fig. 5 .	22306
@NP	Fig.	22306
@NP	5	22311
@NP	central branches of sensory axons	22324
@NP	central branches	22324
@NP	sensory axons	22344
@NP	lumbar DRG	22363
@NP	rostral	22392
@NP	sites of complete transection and SC/OEG or OEG transplantation	22403
@NP	sites	22403
@NP	complete transection and SC/OEG or OEG transplantation	22412
@NP	complete transection	22412
@NP	SC/OEG or OEG transplantation	22437
@NP	Micrograph of a horizontal cryosection	22468
@NP	Micrograph	22468
@NP	a horizontal cryosection	22482
@NP	CTB -LRB- brown -RRB-	22537
@NP	CTB	22537
@NP	brown	22542
@NP	cresyl violet -LRB- blue -RRB-	22573
@NP	cresyl violet	22573
@NP	blue	22588
@NP	a SC/OEG/MEH rat at 22 weeks	22606
@NP	a SC/OEG/MEH rat	22606
@NP	22 weeks	22626
@NP	The site of transection and SC implantation	22636
@NP	The site	22636
@NP	transection and SC implantation	22648
@NP	500 um to the left side of the figure	22683
@NP	500 um	22683
@NP	the left side of the figure	22693
@NP	the left side	22693
@NP	the figure	22710
@NP	the cord caudal to the SC bridge	22722
@NP	the cord caudal	22722
@NP	the SC bridge	22741
@NP	-LRB- A -RRB- Sensory axons	22765
@NP	-LRB- A -RRB-	22765
@NP	Sensory axons	22769
@NP	1 mm	22792
@NP	the site of injury	22802
@NP	the site	22802
@NP	injury	22814
@NP	Scale	22857
@NP	100 μm	22869
@NP	-LRB- B -RRB-	22877
@NP	B	22878
@NP	the boxed region	22893
@NP	-LRB- A -RRB-	22913
@NP	retraction bulbs -LRB- arrows -RRB- at higher magnification	22926
@NP	retraction bulbs -LRB- arrows -RRB-	22926
@NP	retraction bulbs	22926
@NP	arrows	22944
@NP	higher magnification	22955
@NP	Scale	22977
@NP	100 μm	22989
@NP	Fig. 6 .	22998
@NP	Fig.	22998
@NP	6	23003
@NP	Serotonergic axons	23006
@NP	sites of SC/OEG or OEG transplantation	23053
@NP	sites	23053
@NP	SC/OEG or OEG transplantation	23062
@NP	either BH or MEH rats	23095
@NP	BH	23102
@NP	MEH rats	23108
@NP	Micrographs	23118
@NP	horizontal cryosections	23133
@NP	serotonin -LRB- green -RRB- and p75 nerve growth factor receptor -LRB- red -RRB-	23175
@NP	serotonin	23175
@NP	p75 nerve growth factor receptor	23197
@NP	red	23231
@NP	OEG/BH rats , 22 weeks postsurgery	23248
@NP	OEG/BH rats	23248
@NP	22 weeks postsurgery	23261
@NP	22 weeks	23261
@NP	postsurgery	23270
@NP	A	23284
@NP	Descending serotonergic axons	23287
@NP	tissue rostral	23333
@NP	sites of transection	23351
@NP	sites	23351
@NP	transection	23360
@NP	these sites	23390
@NP	The dotted line	23403
@NP	approximate level of transection	23429
@NP	approximate level	23429
@NP	transection	23450
@NP	The asterisk	23463
@NP	approximate level of injection of OEG	23486
@NP	approximate level	23486
@NP	injection of OEG	23507
@NP	injection	23507
@NP	OEG	23520
@NP	Scale	23525
@NP	500 μm	23537
@NP	-LRB- B -RRB- Higher magnification of region	23545
@NP	-LRB- B -RRB- Higher magnification	23545
@NP	-LRB- B -RRB-	23545
@NP	Higher magnification	23549
@NP	region	23573
@NP	A	23590
@NP	Serotonergic axons	23594
@NP	p75-immunoreactive cells	23646
@NP	Scale	23672
@NP	100 μm	23684
@NP	Higher magnification	23696
@NP	a similar region	23720
@NP	a different OEG/BH rat	23746
@NP	longitudinal arrangement of p75-immunoreactive cells	23778
@NP	longitudinal arrangement	23778
@NP	p75-immunoreactive cells	23806
@NP	serotonergic neurons	23832
@NP	transplant sites	23875
@NP	Scale	23893
@NP	100 μm	23905
@NP	3.1	23914
@NP	Mortality	23919
@NP	the OEG-transplanted rats	23932
@NP	5 of 10	23959
@NP	5	23959
@NP	10	23964
@NP	BH	23975
@NP	2 of 9	23986
@NP	2	23986
@NP	9	23991
@NP	MEH	24001
@NP	the SC/OEGtransplanted rats	24009
@NP	1 of 8 in BH	24038
@NP	1	24038
@NP	8 in BH	24043
@NP	8	24043
@NP	BH	24048
@NP	1 of 11 in MEH	24065
@NP	1	24065
@NP	11 in MEH	24070
@NP	11	24070
@NP	MEH	24076
@NP	These differences	24086
@NP	Pearson Chi square	24136
@NP	5.69 , df = 3 , asymmetric two	24157
@NP	5.69 , df = 3 ,	24157
@NP	5.69	24157
@NP	df = 3	24163
@NP	df	24163
@NP	3	24168
@NP	two	24182
@NP	p = 0.128	24192
@NP	p	24192
@NP	0.128	24196
@NP	the nine rats that died after being transferred to BH or MEH	24207
@NP	the nine rats	24207
@NP	BH or MEH	24258
@NP	twice as many	24269
@NP	BH -LRB- n = 6 -RRB-	24303
@NP	BH	24303
@NP	n	24307
@NP	6	24311
@NP	MEH -LRB- n = 3 -RRB-	24320
@NP	MEH	24320
@NP	n	24325
@NP	3	24329
@NP	This difference	24333
@NP	Fisher 's exact test , one-tailed , p = 0.17	24380
@NP	Fisher 's exact test , one-tailed , p	24380
@NP	Fisher 's exact test , one-tailed ,	24380
@NP	Fisher 's exact test	24380
@NP	Fisher 's	24380
@NP	one-tailed	24401
@NP	p	24413
@NP	= 0.17	24415
@NP	the rats that died	24427
@NP	the rats	24427
@NP	7	24447
@NP	OEG transplants and 2	24462
@NP	OEG transplants	24462
@NP	2	24482
@NP	SC/OEG transplants	24497
@NP	This difference	24517
@NP	Fisher 's exact test , two-sided , p = 0.124	24554
@NP	Fisher 's exact test , two-sided , p	24554
@NP	Fisher 's exact test , two-sided ,	24554
@NP	Fisher 's exact test	24554
@NP	Fisher 's	24554
@NP	two-sided	24575
@NP	p	24586
@NP	= 0.124	24588
@NP	3.2	24598
@NP	Motor activity Rats	24603
@NP	BH were often sedentary throughout the 22-week survival period	24644
@NP	BH	24644
@NP	the 22-week survival period	24679
@NP	contrast	24711
@NP	rats housed in MEH	24721
@NP	rats	24721
@NP	MEH	24736
@NP	the 22-week experiment	24770
@NP	Digital movies illustrating these behaviours	24794
@NP	Digital movies	24794
@NP	these behaviours	24822
@NP	request	24856
@NP	L.M.	24869
@NP	communal housing of MEH rats	24883
@NP	communal housing	24883
@NP	MEH rats	24903
@NP	measurement of individual activity	24922
@NP	measurement	24922
@NP	individual activity	24937
@NP	the movie	24958
@NP	rats	24987
@NP	their forelimbs	25009
@NP	ramps and the wire walls	25034
@NP	ramps	25034
@NP	the wire walls	25044
@NP	tunnels	25097
@NP	overnight eating of all	25120
@NP	overnight eating	25120
@NP	all	25140
@NP	the upper cage	25163
@NP	levels	25178
@NP	an indirect measure of cage activity	25195
@NP	an indirect measure	25195
@NP	cage activity	25218
@NP	rats	25251
@NP	the second and third cage levels	25296
@NP	the study	25340
@NP	Hindpaws or tails	25351
@NP	the rungs of the wheels or ramps	25395
@NP	the rungs	25395
@NP	the wheels or ramps	25408
@NP	Hindlimbs	25429
@NP	the rats	25459
@NP	joint movements	25499
@NP	the hindlimbs of many animals	25534
@NP	the hindlimbs	25534
@NP	many animals	25551
@NP	textured ramps	25594
@NP	Rats	25610
@NP	the ground floor in groups of ten to twelve	25643
@NP	the ground floor	25643
@NP	groups of ten to twelve	25663
@NP	groups	25663
@NP	ten to twelve	25673
@NP	3.3	25688
@NP	Hindlimb movement Repeated measures ANOVA	25693
@NP	Hindlimb movement Repeated measures	25693
@NP	ANOVA	25729
@NP	an effect of housing	25744
@NP	an effect	25744
@NP	housing	25757
@NP	OEG-transplanted rats -LRB- F1 ,10 = 5.57 ; p = 0.040 -RRB-	25769
@NP	OEG-transplanted rats	25769
@NP	F1 ,10	25792
@NP	= 5.57 ; p = 0.040	25798
@NP	= 5.57	25798
@NP	p = 0.040	25806
@NP	p	25806
@NP	0.040	25810
@NP	Independent	25818
@NP	measures	25839
@NP	ANOVA	25848
@NP	an effect of housing	25868
@NP	an effect	25868
@NP	housing	25881
@NP	SC/OEG-transplanted rats -LRB- F1 ,15 = 1410 ; p < 0.001 -RRB-	25893
@NP	SC/OEG-transplanted rats	25893
@NP	F1 ,15 = 1410 ; p < 0.001	25919
@NP	F1 ,15 = 1410 ; p <	25919
@NP	F1 ,15 = 1410	25919
@NP	F1 ,15	25919
@NP	1410	25927
@NP	p <	25933
@NP	p	25933
@NP	<	25935
@NP	0.001	25937
@NP	There	25945
@NP	an effect of time	25955
@NP	an effect	25955
@NP	time	25968
@NP	OEG-transplanted rats -LRB- F21 ,210 = 31.1 ; p < 0.001 -RRB-	25977
@NP	OEG-transplanted rats	25977
@NP	F21 ,210	26000
@NP	= 31.1 ; p < 0.001	26008
@NP	= 31.1 ; p <	26008
@NP	= 31.1	26008
@NP	p <	26016
@NP	p	26016
@NP	<	26018
@NP	0.001	26020
@NP	SC/OEG-transplanted rats -LRB- F21 ,315 = 35.7 ; p < 0.001 -RRB-	26035
@NP	SC/OEG-transplanted rats	26035
@NP	F21 ,315	26061
@NP	= 35.7 ; p < 0.001	26069
@NP	= 35.7 ; p <	26069
@NP	= 35.7	26069
@NP	p <	26077
@NP	p	26077
@NP	<	26079
@NP	0.001	26081
@NP	There	26089
@NP	an interaction of housing with time	26104
@NP	an interaction	26104
@NP	housing with time	26122
@NP	housing	26122
@NP	time	26135
@NP	OEG-transplanted rats -LRB- F21 ,210 = 2.51 ; p < 0.001 -RRB-	26144
@NP	OEG-transplanted rats	26144
@NP	F21 ,210 = 2.51 ; p < 0.001	26167
@NP	F21 ,210 = 2.51 ; p <	26167
@NP	F21 ,210 = 2.51	26167
@NP	F21 ,210	26167
@NP	2.51	26177
@NP	p <	26183
@NP	p	26183
@NP	<	26185
@NP	0.001	26187
@NP	SC/OEGtransplanted rats -LRB- F21 ,315 = 5.61 ; p < 0.001 -RRB-	26202
@NP	SC/OEGtransplanted rats	26202
@NP	F21 ,315 = 5.61 ; p < 0.001	26227
@NP	F21 ,315 = 5.61 ; p <	26227
@NP	F21 ,315 = 5.61	26227
@NP	F21 ,315	26227
@NP	5.61	26237
@NP	p <	26243
@NP	p	26243
@NP	<	26245
@NP	0.001	26247
@NP	There	26255
@NP	, therefore , effects	26265
@NP	both housing and time	26289
@NP	the score for open field movement in both OEG and SC/OEG-transplanted rats	26316
@NP	the score	26316
@NP	open field movement in both OEG and SC/OEG-transplanted rats	26330
@NP	open field movement	26330
@NP	both OEG and SC/OEG-transplanted rats	26353
@NP	OEG	26358
@NP	SC/OEG-transplanted rats	26366
@NP	Inspection of BBB scores	26392
@NP	Inspection	26392
@NP	BBB scores	26406
@NP	rats in all groups	26431
@NP	rats	26431
@NP	all groups	26439
@NP	some return of hindlimb joint movement	26463
@NP	some return	26463
@NP	hindlimb joint movement	26478
@NP	the spinal injury	26508
@NP	Figure 3 -LRB- A -RRB-	26527
@NP	Figure 3	26527
@NP	A	26536
@NP	means and standard errors	26547
@NP	the mean -LRB- SEM -RRB-	26576
@NP	the mean	26576
@NP	SEM	26586
@NP	BBB scores	26594
@NP	groups over time	26609
@NP	groups	26609
@NP	time	26621
@NP	all rats	26630
@NP	22 weeks	26653
@NP	Figure 3 -LRB- B -RRB-	26676
@NP	Figure 3	26676
@NP	B	26685
@NP	OEG transplanted groups	26696
@NP	Fig. 3 -LRB- C -RRB- depicts the SC/OEG trans planted groups	26724
@NP	Fig. 3	26724
@NP	C	26731
@NP	the SC/OEG	26742
@NP	groups	26767
@NP	One week	26775
@NP	all groups	26798
@NP	mean scores	26819
@NP	one	26837
@NP	nine weeks	26854
@NP	all rats	26866
@NP	mean hindlimb scores	26879
@NP	seven or more	26903
@NP	Table	26918
@NP	1 -RRB- , corresponding to extensive movement of all three joints of hindlimbs	26924
@NP	1 -RRB- , corresponding to extensive movement of all three joints	26924
@NP	corresponding to extensive movement of all three joints	26928
@NP	corresponding	26928
@NP	extensive movement	26945
@NP	all three joints	26967
@NP	hindlimbs	26987
@NP	26	26998
@NP	14 weeks	27006
@NP	100 % of rats housed in MEH	27029
@NP	100 %	27029
@NP	rats housed in MEH	27037
@NP	rats	27037
@NP	MEH	27052
@NP	BBB scores of at least seven	27066
@NP	BBB scores	27066
@NP	at least seven	27080
@NP	this	27103
@NP	80 % of OEG/BH and 29 % of SC/OEG/BH rats	27126
@NP	80 % of OEG/BH	27126
@NP	80 %	27126
@NP	OEG/BH	27133
@NP	29 % of SC/OEG/BH rats	27144
@NP	29 %	27144
@NP	SC/OEG/BH rats	27151
@NP	22 weeks	27170
@NP	100 % of OEG/MEH rats and 60 % of SC/OEG/MEH rats	27193
@NP	100 % of OEG/MEH rats	27193
@NP	100 %	27193
@NP	OEG/MEH rats	27201
@NP	60 % of SC/OEG/MEH rats	27218
@NP	60 %	27218
@NP	SC/OEG/MEH rats	27225
@NP	scores equal to or greater	27245
@NP	scores	27245
@NP	or greater	27261
@NP	seven	27277
@NP	this	27292
@NP	only 29 % of OEG/BH rats and 14 % of SC/OEG/BH rats -LRB- Table 1 -RRB-	27310
@NP	only 29 % of OEG/BH rats	27310
@NP	only 29 %	27310
@NP	OEG/BH rats	27322
@NP	14 % of SC/OEG/BH rats -LRB- Table 1 -RRB-	27338
@NP	14 %	27338
@NP	SC/OEG/BH rats -LRB- Table 1 -RRB-	27345
@NP	SC/OEG/BH rats	27345
@NP	Table 1	27361
@NP	the 22-week testing period	27376
@NP	no BH rat	27404
@NP	mean hindlimb scores	27428
@NP	eight	27455
@NP	contrast	27465
@NP	three SC/OEG/MEH rats	27475
@NP	peak mean hindlimb scores of nine and one OEG/MEH rat obtained 10.5	27506
@NP	peak mean hindlimb scores of nine	27506
@NP	peak mean hindlimb scores	27506
@NP	nine	27535
@NP	one OEG/MEH rat obtained 10.5	27544
@NP	one OEG/MEH rat	27544
@NP	10.5	27569
@NP	this OEG/MEH rat	27583
@NP	a score of nine or more from three to 22 weeks	27622
@NP	a score	27622
@NP	nine or more from three to 22 weeks	27633
@NP	nine or more	27633
@NP	three to 22 weeks	27651
@NP	Several lines of evidence	27683
@NP	Several lines	27683
@NP	evidence	27700
@NP	transectionwas complete in this rat	27723
@NP	transectionwas	27723
@NP	this rat	27750
@NP	considerable care	27767
@NP	surgery	27802
@NP	the spinal cord	27817
@NP	all rats including dura and all lateral and ventral tissue	27847
@NP	all rats	27847
@NP	dura and all lateral and ventral tissue	27866
@NP	dura	27866
@NP	all lateral and ventral tissue	27875
@NP	one week post-surgery	27915
@NP	one week	27915
@NP	this rat 's mean hindlimb BBB score	27938
@NP	this rat 's	27938
@NP	1.0	27977
@NP	histology	27989
@NP	no evidence for sparing	28008
@NP	no evidence	28008
@NP	regeneration across the injury site in this rat -LRB- see below -RRB-	28035
@NP	regeneration	28035
@NP	the injury site in this rat -LRB- see below -RRB-	28055
@NP	the injury site	28055
@NP	this rat	28074
@NP	the time points at which differences betweenBH andMEHgroups were significant	28108
@NP	the time points	28108
@NP	differences betweenBH andMEHgroups	28133
@NP	one-tailed t-tests	28186
@NP	13	28225
@NP	22 weeks postinjury inclusive	28231
@NP	22 weeks	28231
@NP	These	28262
@NP	SC/OEG-transplanted and OEG-transplanted rats	28298
@NP	Tables 2 and 3 , respectively	28345
@NP	Tables 2 and 3	28345
@NP	adjusted levels of significance	28381
@NP	adjusted levels	28381
@NP	significance	28400
@NP	p < 0.005	28424
@NP	p	28424
@NP	< 0.005	28426
@NP	<	28426
@NP	0.005	28428
@NP	differences	28436
@NP	BH and MEH	28470
@NP	rats transplanted with SC/OEG at weeks 14	28484
@NP	rats	28484
@NP	SC/OEG at weeks	28507
@NP	SC/OEG	28507
@NP	weeks	28517
@NP	14	28523
@NP	18 and 21 and trends	28527
@NP	18 and 21	28527
@NP	trends	28541
@NP	weeks 19 and 20 -LRB- p = 0.013 and 0.0059 , respectively -RRB-	28565
@NP	weeks 19 and 20	28565
@NP	p = 0.013 and 0.0059 , respectively	28582
@NP	p = 0.013 and 0.0059	28582
@NP	p	28582
@NP	0.013 and 0.0059	28586
@NP	14 weeks	28622
@NP	group scores -LRB- means ± SEM -RRB-	28645
@NP	group scores	28645
@NP	means	28659
@NP	SEM	28665
@NP	8.0 ± 0.0	28675
@NP	SC/OEG/MEH versus 4.6 ± 0.8 for SC/OEG/BH	28689
@NP	SC/OEG/MEH	28689
@NP	4.6 ± 0.8	28707
@NP	SC/OEG/BH	28721
@NP	22 weeks	28735
@NP	group	28758
@NP	scores	28769
@NP	6.0 ± 0.5	28781
@NP	SC/OEG/MEH versus 4.9 ± 0.5 for SC/OEG/BH	28795
@NP	SC/OEG/MEH	28795
@NP	4.9 ± 0.5	28813
@NP	SC/OEG/BH	28827
@NP	SC/OEG-transplanted rats	28843
@NP	hindlimb locomotor function in both types of housing -LRB- BH and MEH -RRB-	28876
@NP	hindlimb locomotor function	28876
@NP	both types of housing -LRB- BH and MEH -RRB-	28907
@NP	both types	28907
@NP	housing -LRB- BH and MEH -RRB-	28921
@NP	housing	28921
@NP	BH and MEH	28930
@NP	BH	28930
@NP	MEH	28937
@NP	Rats in BH	28943
@NP	Rats	28943
@NP	BH	28951
@NP	hindlimb function	28983
@NP	14 weeks	29006
@NP	this	29036
@NP	rats in MEH	29059
@NP	rats	29059
@NP	MEH	29067
@NP	21 weeks	29087
@NP	adjusted levels of significance	29102
@NP	adjusted levels	29102
@NP	significance	29121
@NP	p < 0.005	29145
@NP	p	29145
@NP	< 0.005	29147
@NP	<	29147
@NP	0.005	29149
@NP	differences	29157
@NP	BH and MEHrats	29195
@NP	OEG	29228
@NP	any timepoint from 13	29235
@NP	any timepoint	29235
@NP	13	29254
@NP	22 weeks post-transplantation -LRB- Table 3 -RRB-	29260
@NP	22 weeks post-transplantation	29260
@NP	Table 3	29291
@NP	Inspection of mean differences and p values -LRB- Table 3 -RRB-	29301
@NP	Inspection of mean differences and p values	29301
@NP	Inspection	29301
@NP	mean differences and p values	29315
@NP	Table 3	29346
@NP	hindlimb scores for MEH rats	29366
@NP	hindlimb scores	29366
@NP	MEH rats	29386
@NP	those for BH	29417
@NP	those	29417
@NP	BH	29427
@NP	this trend	29439
@NP	significance	29464
@NP	levels of significance	29482
@NP	levels	29482
@NP	significance	29492
@NP	Bonferroni 's correction	29524
@NP	Bonferroni 's	29524
@NP	14 weeks	29552
@NP	group scores -LRB- means ± SEM -RRB-	29575
@NP	group scores	29575
@NP	means	29589
@NP	SEM	29597
@NP	8.4 ± 0.5	29607
@NP	OEG/MEH versus 6.9 ± 0.4 for OEG/BH	29621
@NP	OEG/MEH	29621
@NP	6.9 ± 0.4	29636
@NP	OEG/BH	29649
@NP	22 weeks	29660
@NP	group	29683
@NP	scores	29694
@NP	7.8 ± 0.3	29706
@NP	OEG/MEH versus 5.4 ± 0.8 for OEG/BH	29720
@NP	OEG/MEH	29720
@NP	5.4 ± 0.8	29735
@NP	OEG/BH	29749
@NP	summary	29760
@NP	OEG-transplanted rats	29769
@NP	hindlimb function	29799
@NP	both types of housing -LRB- BH and MEH -RRB-	29820
@NP	both types	29820
@NP	housing -LRB- BH and MEH -RRB-	29834
@NP	housing	29834
@NP	BH and MEH	29843
@NP	BH	29843
@NP	MEH	29850
@NP	OEGtransplanted rats in BH	29856
@NP	OEGtransplanted rats	29856
@NP	BH	29880
@NP	function over time	29898
@NP	function	29898
@NP	time	29912
@NP	a significant difference	29921
@NP	any specific timepoint	29971
@NP	BBB testing	30002
@NP	observers blind to treatment condition	30015
@NP	observers	30015
@NP	treatment condition	30034
@NP	the incidence of crawling	30063
@NP	the incidence	30063
@NP	a hindlimb behavior that is not represented within the BBB rating scale	30090
@NP	a hindlimb behavior	30090
@NP	the BBB rating scale	30141
@NP	Crawling	30163
@NP	multiple -LRB- > 3 cycles -RRB-	30187
@NP	multiple	30187
@NP	> 3 cycles	30197
@NP	>	30197
@NP	3 cycles	30199
@NP	extensive movements of two or three hindlimb joints	30221
@NP	extensive movements	30221
@NP	two or three hindlimb joints	30244
@NP	two	30244
@NP	three hindlimb joints	30251
@NP	body weight being supported on the knee joints throughout	30279
@NP	body weight	30279
@NP	the knee joints	30310
@NP	A digital movie illustrating this behaviour	30338
@NP	A digital movie	30338
@NP	this behaviour	30367
@NP	request	30398
@NP	L.M.	30411
@NP	Crawling	30416
@NP	rats nine weeks	30444
@NP	rats	30444
@NP	nine weeks	30449
@NP	injury	30466
@NP	i.e. , rats that exhibited crawling usually	30513
@NP	i.e.	30513
@NP	rats that exhibited crawling usually	30519
@NP	rats	30519
@NP	instances of crawling in all BBB testing sessions thereafter	30566
@NP	instances	30566
@NP	all BBB testing sessions	30591
@NP	16 of 17 rats housed in MEH	30637
@NP	16	30637
@NP	17 rats housed in MEH	30643
@NP	17 rats	30643
@NP	MEH	30661
@NP	one or more instances of crawling relative to 5 of 12 rats housed in BH	30675
@NP	one or more instances	30675
@NP	5 of 12 rats housed in BH	30721
@NP	5	30721
@NP	12 rats housed in BH	30726
@NP	12 rats	30726
@NP	BH	30744
@NP	Evaluation using a one-tailed Fisher 's exact test	30748
@NP	Evaluation	30748
@NP	a one-tailed Fisher 's exact test	30765
@NP	Fisher 's	30778
@NP	this effect	30812
@NP	p = 0.003	30841
@NP	p	30841
@NP	= 0.003	30843
@NP	3.4	30853
@NP	Growth	30858
@NP	axons	30868
@NP	SC bridges	30879
@NP	implantation of bridges containing SCs in fibrin	30906
@NP	implantation	30906
@NP	bridges containing SCs in fibrin	30922
@NP	bridges	30922
@NP	SCs in fibrin	30941
@NP	SCs	30941
@NP	fibrin	30948
@NP	growth and myelination of axons , transverse semi-thin sections	30967
@NP	growth and myelination	30967
@NP	axons , transverse semi-thin sections	30993
@NP	axons	30993
@NP	transverse semi-thin sections	31000
@NP	SC grafts	31038
@NP	n = 3	31062
@NP	n	31062
@NP	= 3	31064
@NP	Large numbers of axons	31070
@NP	Large numbers	31070
@NP	axons	31087
@NP	SC bridges	31103
@NP	peripheral	31128
@NP	Figure 4 -LRB- A -RRB-	31147
@NP	Figure 4	31147
@NP	A	31156
@NP	a region	31167
@NP	a SC graft taken from a rat housed in MEH at 12 weeks after transplantation	31179
@NP	a SC graft	31179
@NP	a rat housed in MEH at 12 weeks after transplantation	31201
@NP	a rat	31201
@NP	MEH	31217
@NP	12 weeks	31224
@NP	transplantation	31239
@NP	Figure 4 -LRB- B -RRB-	31256
@NP	Figure 4	31256
@NP	B	31265
@NP	axons at higher magnification	31298
@NP	axons	31298
@NP	higher magnification	31307
@NP	Grafts	31329
@NP	13,279 SC-myelinated axons and up to 273 blood vessel profiles	31352
@NP	13,279 SC-myelinated axons	31352
@NP	up to 273 blood vessel profiles	31383
@NP	Statistical comparisons between groups	31416
@NP	Statistical comparisons	31416
@NP	groups	31448
@NP	only three cords	31477
@NP	transverse semi-thin sectioning	31513
@NP	cords	31546
@NP	rats	31557
@NP	the full length of the study	31580
@NP	the full length	31580
@NP	the study	31599
@NP	axons	31665
@NP	grafts	31699
@NP	These data	31708
@NP	SC transplants	31755
@NP	growth and myelination	31778
@NP	axons , as seen in previous studies from this laboratory -LSB- 13,27 -RSB-	31804
@NP	axons	31804
@NP	previous studies	31822
@NP	this laboratory -LSB- 13,27 -RSB-	31844
@NP	this laboratory	31844
@NP	13,27 -RSB-	31861
@NP	These axons	31869
@NP	sensory and spinal cord neurons	31905
@NP	cell bodies proximal to transplants -LSB- 10,13 -RSB-	31942
@NP	cell bodies	31942
@NP	transplants -LSB- 10,13 -RSB-	31966
@NP	transplants	31966
@NP	10,13 -RSB-	31979
@NP	The functional significance of the presence of these axons within grafts	31987
@NP	The functional significance	31987
@NP	the presence of these axons within grafts	32018
@NP	the presence	32018
@NP	these axons within grafts	32034
@NP	these axons	32034
@NP	grafts	32053
@NP	3.5	32089
@NP	the central branch of sensory axons	32117
@NP	the central branch	32117
@NP	sensory axons	32139
@NP	the right hindlimb sciatic nerve	32158
@NP	a transganglionic tracer , CTB	32192
@NP	a transganglionic tracer	32192
@NP	CTB	32218
@NP	three days	32236
@NP	the end of the experiment	32256
@NP	the end	32256
@NP	the experiment	32267
@NP	Figure 5 shows	32283
@NP	sensory axons ascending within the dorsal columns	32303
@NP	sensory axons	32303
@NP	the dorsal columns	32334
@NP	transection	32384
@NP	22 weeks	32404
@NP	approximately 1 mm	32441
@NP	Regeneration of these axons into transplantation sites	32461
@NP	Regeneration	32461
@NP	these axons into transplantation sites	32477
@NP	these axons	32477
@NP	transplantation sites	32494
@NP	any rat , whether in SC/OEG orOEG groups , or whether housed in BH or MEH	32532
@NP	any rat	32532
@NP	SC/OEG orOEG groups	32552
@NP	BH or MEH	32594
@NP	3.6	32605
@NP	Serotonergic axons Serotonergic axons	32610
@NP	Serotonergic axons	32610
@NP	Serotonergic axons	32629
@NP	spinal cord rostral	32664
@NP	sites of transection/transplantation	32687
@NP	sites	32687
@NP	transection/transplantation	32696
@NP	injury sites	32762
@NP	any rat , whether in SC/OEG or OEG groups or whether housed in BH or MEH	32778
@NP	any rat	32778
@NP	SC/OEG or OEG groups	32798
@NP	BH or MEH	32840
@NP	Figure 6 -LRB- A -RRB- and -LRB- B -RRB- , taken from an OEG/BH rat ,	32851
@NP	Figure 6 -LRB- A -RRB-	32851
@NP	Figure 6	32851
@NP	A	32860
@NP	-LRB- B -RRB- , taken from an OEG/BH rat ,	32867
@NP	-LRB- B -RRB-	32867
@NP	an OEG/BH rat	32883
@NP	serotonergic axons in spinal cord rostral	32906
@NP	serotonergic axons	32906
@NP	spinal cord rostral	32928
@NP	the site of transection	32951
@NP	the site	32951
@NP	transection	32963
@NP	Serotonergic axons	32994
@NP	the site of transection	33039
@NP	the site	33039
@NP	transection	33051
@NP	Figure 6 -LRB- C -RRB-	33064
@NP	Figure 6	33064
@NP	C	33073
@NP	another OEG/BH rat	33088
@NP	an equivalent field of view	33113
@NP	an equivalent field	33113
@NP	view	33136
@NP	serotonergic axons	33153
@NP	the site of transection	33192
@NP	the site	33192
@NP	transection	33204
@NP	Serotonergic axons	33217
@NP	p75 immunoreac tive cells -LRB- whether host SCs or transplanted OEG -RRB-	33257
@NP	p75 immunoreac tive cells	33257
@NP	host SCs or transplanted OEG	33292
@NP	host SCs	33292
@NP	transplanted OEG	33304
@NP	their longitudinal orientation	33331
@NP	p75 - immunoreactive cells	33377
@NP	p75	33377
@NP	immunoreactive cells	33382
@NP	chains of cells	33425
@NP	chains	33425
@NP	cells	33435
@NP	proximal spinal roots	33457
@NP	many SCs	33496
@NP	the injury site	33519
@NP	the PNS	33540
@NP	data not shown	33549
@NP	data	33549
@NP	contrast to previous experiments -LSB- 14 -RSB-	33569
@NP	contrast	33569
@NP	previous experiments -LSB- 14 -RSB-	33581
@NP	previous experiments	33581
@NP	14 -RSB-	33603
@NP	serotonergic axons	33608
@NP	connective tissue surroundingSC bridges -LRB- data not shown -RRB-	33661
@NP	connective tissue surroundingSC bridges	33661
@NP	data not shown	33702
@NP	data	33702
@NP	Discussion Rats	33723
@NP	MEH	33761
@NP	them	33781
@NP	opportunities	33802
@NP	motor selfrehabilitation	33820
@NP	contrast	33849
@NP	rats in BH	33859
@NP	rats	33859
@NP	BH	33867
@NP	MEH	33900
@NP	a beneficial effect	33908
@NP	hindlimb movements	33931
@NP	BBB tests between one	33966
@NP	BBB tests	33966
@NP	one	33984
@NP	22 weeks	33992
@NP	differences between BH and MEH rats	34029
@NP	differences	34029
@NP	BH and MEH rats	34049
@NP	OEG-transplanted rats	34088
@NP	SC/OEGtransplanted rats	34118
@NP	Very modest improvements in hindlimb locomotor function	34143
@NP	Very modest improvements	34143
@NP	hindlimb locomotor function	34171
@NP	all groups , whether maintained in BH or MEH	34216
@NP	all groups	34216
@NP	BH or MEH	34250
@NP	One week following surgery , all group	34261
@NP	One week	34261
@NP	surgery , all group	34280
@NP	surgery	34280
@NP	all group	34289
@NP	BBB scores	34304
@NP	one	34326
@NP	flaccid paralysis with slight movement of one or two hindlimb joints	34338
@NP	flaccid paralysis	34338
@NP	slight movement of one or two hindlimb joints	34361
@NP	slight movement	34361
@NP	one or two hindlimb joints	34380
@NP	nine weeks	34411
@NP	post-surgery every rat	34422
@NP	a mean hindlimb score of at least seven	34449
@NP	a mean hindlimb score	34449
@NP	at least seven	34474
@NP	extensive movement of all three joints of the hindlimb -LSB- 26 -RSB-	34507
@NP	extensive movement	34507
@NP	all three joints of the hindlimb -LSB- 26 -RSB-	34529
@NP	all three joints	34529
@NP	the hindlimb -LSB- 26 -RSB-	34549
@NP	the hindlimb	34549
@NP	26 -RSB-	34563
@NP	the 22-week testing period	34573
@NP	no BH rat	34601
@NP	mean hindlimb scores	34625
@NP	eight	34652
@NP	contrast	34662
@NP	three SC/OEG/MEH rats	34672
@NP	peak mean hindlimb scores of nine and one OEG/MEH rat obtained 10.5	34703
@NP	peak mean hindlimb scores of nine	34703
@NP	peak mean hindlimb scores	34703
@NP	nine	34732
@NP	one OEG/MEH rat obtained 10.5	34741
@NP	one OEG/MEH rat	34741
@NP	10.5	34766
@NP	special note	34775
@NP	this OEG/MEH rat	34789
@NP	a score of nine or more from three to 22 weeks	34828
@NP	a score	34828
@NP	nine or more from three to 22 weeks	34839
@NP	nine or more	34839
@NP	three to 22 weeks	34857
@NP	peak performance of BH rats	34895
@NP	peak performance	34895
@NP	BH rats	34915
@NP	Sweeping with no weight support	34940
@NP	Sweeping	34940
@NP	no weight support	34954
@NP	plantar placement of the pawwith no weight support	34976
@NP	plantar placement of the pawwith	34976
@NP	plantar placement	34976
@NP	the pawwith	34997
@NP	no weight support	35009
@NP	BBB = 8	35029
@NP	contrast	35042
@NP	peak performance of SC/OEG/MEH rats	35052
@NP	peak performance	35052
@NP	SC/OEG/MEH rats	35072
@NP	Plantar placement	35105
@NP	the paw with weight support	35126
@NP	the paw	35126
@NP	weight support	35139
@NP	stance only '' or `` Occasional	35157
@NP	stance only	35157
@NP	Occasional	35174
@NP	frequent or consistent weight supported dorsal stepping	35186
@NP	frequent or consistent weight	35186
@NP	dorsal stepping	35226
@NP	dorsal	35226
@NP	no plantar stepping	35246
@NP	no plantar	35246
@NP	BBB = 9	35268
@NP	peak performance of OEG/MEH rats	35283
@NP	peak performance	35283
@NP	OEG/MEH rats	35303
@NP	Occasional weight	35333
@NP	plantar steps	35361
@NP	no forelimb-hindlimb coordination	35380
@NP	BBB = 10	35416
@NP	26 -RSB-	35427
@NP	Improvements in hindlimb movements	35432
@NP	Improvements	35432
@NP	hindlimb movements	35448
@NP	22 weeks in the majority of MEH rats	35488
@NP	22 weeks	35488
@NP	the majority of MEH rats	35500
@NP	the majority	35500
@NP	MEH rats	35516
@NP	contrast	35529
@NP	hindlimb movements of the majority of rats in BH	35539
@NP	hindlimb movements	35539
@NP	the majority of rats in BH	35561
@NP	the majority	35561
@NP	rats in BH	35577
@NP	rats	35577
@NP	BH	35585
@NP	scores	35618
@NP	7	35631
@NP	Repeated measures ANOVA	35634
@NP	Repeated measures	35634
@NP	ANOVA	35652
@NP	differences	35667
@NP	BH and MEH rats	35687
@NP	OEG-transplanted and SC/OEG-transplanted rats	35712
@NP	Post hoc tests of BBB data for 13 to 22 weeks post-surgery	35759
@NP	Post	35759
@NP	hoc tests	35764
@NP	BBB data for 13 to 22 weeks post-surgery	35777
@NP	BBB data	35777
@NP	13 to 22 weeks post-surgery	35790
@NP	13 to 22 weeks	35790
@NP	the decline in function	35830
@NP	the decline	35830
@NP	function	35845
@NP	significant 14 weeks postsurgery	35861
@NP	14 weeks	35873
@NP	SC/OEG/BH rats	35897
@NP	The onset of decline	35913
@NP	The onset	35913
@NP	decline	35926
@NP	OEG-transplanted rats	35956
@NP	significance levels adjusted using Bonferroni 's correction	35984
@NP	significance levels	35984
@NP	Bonferroni 's correction	36019
@NP	Bonferroni 's	36019
@NP	a difference betweenBH andMEH rats	36066
@NP	OEG	36119
@NP	repeated ANOVA but not by numerous post hoc tests	36126
@NP	ANOVA	36135
@NP	numerous post	36152
@NP	significance levels adjusted for multiple testing	36181
@NP	significance levels	36181
@NP	multiple testing	36214
@NP	differences in statistical power	36245
@NP	differences	36245
@NP	statistical power	36260
@NP	the SC/OEG comparison	36282
@NP	there	36305
@NP	7 rats in BH and 10 rats in MEH	36316
@NP	7 rats in BH	36316
@NP	7 rats	36316
@NP	BH	36326
@NP	10 rats in MEH	36333
@NP	10 rats	36333
@NP	MEH	36344
@NP	the OEG comparions	36352
@NP	there	36372
@NP	only 5 rats in BH and 7 in MEH	36383
@NP	only 5 rats in BH	36383
@NP	only 5 rats	36383
@NP	BH	36398
@NP	7 in MEH	36405
@NP	7	36405
@NP	MEH	36410
@NP	Smaller ` n 's in the OEG groups	36415
@NP	Smaller	36415
@NP	n	36424
@NP	the OEG groups	36431
@NP	increased SEMs -LRB- standard deviation/square root of n -RRB-	36456
@NP	increased SEMs	36456
@NP	standard deviation/square root of n	36472
@NP	standard deviation/square root	36472
@NP	n	36506
@NP	a resulting loss of statistical power	36513
@NP	a resulting loss	36513
@NP	statistical power	36533
@NP	Increased SEMs for the OEG groups	36552
@NP	Increased SEMs	36552
@NP	the OEG groups	36571
@NP	SC/OEG groups	36598
@NP	Figures 3 -LRB- B -RRB- and 3 -LRB- C -RRB-	36627
@NP	Figures 3	36627
@NP	B	36637
@NP	3	36644
@NP	C	36646
@NP	The relatively small numbers of rats per group completing this study	36663
@NP	The relatively small numbers	36663
@NP	rats per group completing this study	36695
@NP	rats	36695
@NP	group completing this study	36704
@NP	group	36704
@NP	this study	36721
@NP	an undesired consequence	36736
@NP	rats	36776
@NP	complete transection injuries -LRB- with transplants -RRB- for many months	36786
@NP	complete transection injuries -LRB- with transplants -RRB-	36786
@NP	complete transection injuries	36786
@NP	transplants	36822
@NP	many months	36839
@NP	The decline in function detected in SC/OEG/BH rats	36852
@NP	The decline	36852
@NP	function detected in SC/OEG/BH rats	36867
@NP	function	36867
@NP	SC/OEG/BH rats	36888
@NP	the more severe injury	36922
@NP	removal	36956
@NP	a two-millimeter segment	36967
@NP	spinal cord in SC/OEG rats -LRB- relative to transection only in OEG rats -RRB-	36995
@NP	spinal cord	36995
@NP	SC/OEG rats -LRB- relative to transection only in OEG rats -RRB-	37010
@NP	SC/OEG rats	37010
@NP	transection only in OEG rats	37035
@NP	transection only	37035
@NP	OEG rats	37055
@NP	Degeneration in the spinal cord	37066
@NP	Degeneration	37066
@NP	the spinal cord	37082
@NP	one millimetre	37105
@NP	excision of a two millimetre segment	37168
@NP	excision	37168
@NP	a two millimetre segment	37180
@NP	this	37206
@NP	lumbar spinal cord regions involved in hindlimb function -LSB- 28 -RSB-	37236
@NP	lumbar spinal cord regions	37236
@NP	hindlimb function -LSB- 28 -RSB-	37275
@NP	hindlimb function	37275
@NP	28 -RSB-	37294
@NP	the rats in the present study	37307
@NP	the rats	37307
@NP	the present study	37319
@NP	approximately one year	37342
@NP	the experiment	37374
@NP	senescence	37404
@NP	not a factor in causing the progressive decline	37428
@NP	not a factor	37428
@NP	the progressive decline	37452
@NP	rats housed in BH	37489
@NP	rats	37489
@NP	BH	37504
@NP	more rats housed in MEH	37508
@NP	more rats	37508
@NP	MEH	37528
@NP	Crawling	37552
@NP	multiple -LRB- > 3 cycles -RRB- , alternating	37576
@NP	multiple	37576
@NP	> 3 cycles	37586
@NP	>	37586
@NP	3 cycles	37588
@NP	extensive movements of two	37612
@NP	extensive movements	37612
@NP	two	37635
@NP	three hindlimb joints	37642
@NP	body weight being supported on the knees rather than paws	37670
@NP	body weight	37670
@NP	the knees rather than paws	37701
@NP	the knees	37701
@NP	paws	37723
@NP	Crawling	37729
@NP	sensory stimulation of the hindlimbs	37781
@NP	sensory stimulation	37781
@NP	the hindlimbs	37804
@NP	rats	37824
@NP	forelimbs	37834
@NP	the various textured surfaces	37857
@NP	the enriched environment	37890
@NP	mechanical linkage of torso or forelimb movements	37922
@NP	mechanical linkage	37922
@NP	torso or forelimb movements	37944
@NP	Transplantation	37973
@NP	we	38036
@NP	this behaviour in non-transplanted rats	38050
@NP	this behaviour	38050
@NP	non-transplanted rats	38068
@NP	spinal cords	38106
@NP	The maximal mean	38120
@NP	BBB scores	38137
@NP	many of the OEG and SC/OEG rats	38160
@NP	many	38160
@NP	the OEG and SC/OEG rats	38168
@NP	the present study	38195
@NP	those	38238
@NP	some other studies using thoracic complete transection as an injury model	38256
@NP	some other studies	38256
@NP	thoracic complete transection	38281
@NP	an injury model	38314
@NP	several of these studies , one or more transplanted rats	38981
@NP	several	38981
@NP	these studies , one or more transplanted rats	38992
@NP	these studies	38992
@NP	one or more transplanted rats	39007
@NP	scores of 10	39046
@NP	scores	39046
@NP	10	39056
@NP	thoracic transection and intervention of any kind , plantar placement	39069
@NP	thoracic transection and intervention	39069
@NP	any kind , plantar placement	39110
@NP	any kind	39110
@NP	plantar placement	39120
@NP	weight support of the hindlimbs and/or forelimb-hindlimb coordination	39139
@NP	weight support	39139
@NP	the hindlimbs and/or forelimb-hindlimb coordination	39157
@NP	the hindlimbs	39157
@NP	forelimb-hindlimb coordination	39178
@NP	the exception	39217
@NP	our knowledge	39235
@NP	only one study	39250
@NP	high incidences of plantar placement and weight-supported	39273
@NP	high incidences	39273
@NP	plantar placement and weight-supported	39292
@NP	plantar placement	39292
@NP	weight-supported	39314
@NP	rats	39343
@NP	transection injuries	39353
@NP	conventional BBB testing	39384
@NP	This study combined grafting	39429
@NP	fetal tissue two weeks post-injury with neurotrophin treatment	39461
@NP	fetal tissue	39461
@NP	two weeks	39474
@NP	neurotrophin treatment	39501
@NP	33 -RSB-	39525
@NP	conclusion	39533
@NP	more work	39545
@NP	consistent plantar placement and weightsupported	39584
@NP	consistent plantar placement	39584
@NP	weightsupported	39617
@NP	adults rats with complete transection injury	39645
@NP	adults rats	39645
@NP	complete transection injury	39662
@NP	Transection-only controls	39691
@NP	the present study	39738
@NP	experience in our laboratory	39764
@NP	experience	39764
@NP	our laboratory	39778
@NP	adult rats with complete thoracic spinal cord transections	39822
@NP	adult rats	39822
@NP	complete thoracic spinal cord transections	39838
@NP	extensive movements	39896
@NP	more than a single hindlimb joint -LRB- BBB score < 2 -RRB- -LSB- 17	39919
@NP	more than a single hindlimb joint	39919
@NP	BBB score < 2	39954
@NP	BBB score	39954
@NP	< 2	39964
@NP	<	39964
@NP	2	39966
@NP	-LSB- 17	39969
@NP	19,26,29 -RSB-	39973
@NP	one year	39995
@NP	post-injury -LSB- 34 -RSB-	40004
@NP	post-injury -LSB-	40004
@NP	Improvements in open field hindlimb movement	40022
@NP	Improvements	40022
@NP	open field hindlimb movement	40038
@NP	transected non-transplanted rats	40083
@NP	long-term training/testing on an inclined plane task -LSB- 16 -RSB-	40131
@NP	long-term training/testing	40131
@NP	an inclined plane task -LSB- 16 -RSB-	40161
@NP	an inclined plane task	40161
@NP	16 -RSB-	40185
@NP	Motor enrichment therapies	40190
@NP	only slight benefit	40225
@NP	open field locomotion in much milder forms of injury	40248
@NP	open field locomotion	40248
@NP	much milder forms of injury	40273
@NP	much milder forms	40273
@NP	injury	40294
@NP	moderate thoracic contusion -LSB- 1 -RSB-	40320
@NP	moderate thoracic contusion	40320
@NP	1 -RSB-	40349
@NP	We	40353
@NP	it	40370
@NP	enrichment	40387
@NP	significant improvement	40412
@NP	transected rats	40439
@NP	grafts	40463
@NP	We	40471
@NP	our conclusions in this study	40489
@NP	our conclusions	40489
@NP	this study	40508
@NP	comparisons between BH and MEH	40532
@NP	comparisons	40532
@NP	BH and MEH	40552
@NP	rats	40570
@NP	transplanted	40575
@NP	OEG or SCs with OEG	40600
@NP	OEG or SCs	40600
@NP	OEG	40616
@NP	the need for comparison	40629
@NP	the need	40629
@NP	comparison	40642
@NP	transection-only controls	40656
@NP	Recovery of hindlimb movements after transection	40683
@NP	Recovery	40683
@NP	hindlimb movements after transection	40695
@NP	hindlimb movements	40695
@NP	transection	40720
@NP	regrowth of serotonergic fibers	40751
@NP	regrowth	40751
@NP	serotonergic fibers	40763
@NP	lumbar spinal regions -LSB- 16,35 -RSB-	40786
@NP	lumbar spinal regions	40786
@NP	16,35 -RSB-	40809
@NP	the present study	40820
@NP	we	40839
@NP	recovery	40851
@NP	hindlimb function	40863
@NP	that reported in these studies -LRB- up to a BBB of 10.5 -RRB-	40895
@NP	that	40895
@NP	these studies	40912
@NP	a BBB of 10.5	40933
@NP	a BBB	40933
@NP	10.5	40942
@NP	evidence of regeneration of descending serotonergic axons	40960
@NP	evidence	40960
@NP	regeneration of descending serotonergic axons	40972
@NP	regeneration	40972
@NP	descending serotonergic axons	40988
@NP	our method of OEG preparation	41028
@NP	our method	41028
@NP	OEG preparation	41042
@NP	that of other groups	41074
@NP	that	41074
@NP	other groups	41082
@NP	serotonergic regeneration after transection	41096
@NP	serotonergic regeneration	41096
@NP	transection	41128
@NP	OEG prepared in our laboratory -LSB- 19 -RSB-	41164
@NP	OEG	41164
@NP	our laboratory -LSB- 19 -RSB-	41180
@NP	our laboratory	41180
@NP	19 -RSB-	41196
@NP	the present study	41204
@NP	transections	41232
@NP	previous studies	41279
@NP	other transection/OEG transplantation studies	41312
@NP	ventral dura	41358
@NP	17 -RSB-	41383
@NP	ventral dura	41388
@NP	our transection / OEG rats	41412
@NP	our transection	41412
@NP	OEG rats	41429
@NP	The present study	41439
@NP	SCs	41470
@NP	fibrin rather than Matrigel -LSB- 14,19 -RSB-	41481
@NP	fibrin	41481
@NP	Matrigel -LSB- 14,19 -RSB-	41500
@NP	Matrigel -LSB-	41500
@NP	14,19 -RSB-	41510
@NP	a polymer hemichannel roof above grafts	41531
@NP	a polymer hemichannel roof	41531
@NP	grafts	41564
@NP	an intact polymer channel that enclosed grafts	41583
@NP	an intact polymer channel	41583
@NP	grafts	41623
@NP	Serotonergic fibers	41631
@NP	connective tissue on the roof 's external surface in contrast	41668
@NP	connective tissue	41668
@NP	the roof 's external surface in contrast	41689
@NP	the roof 's external surface	41689
@NP	the roof 's	41689
@NP	contrast	41720
@NP	the presence of these fibers	41732
@NP	the presence	41732
@NP	these fibers	41748
@NP	intact channels -LSB- 14 -RSB-	41768
@NP	intact channels	41768
@NP	14 -RSB-	41785
@NP	the latter study	41793
@NP	fibers	41811
@NP	the spinal cord caudal	41829
@NP	the channel/SC transplant	41855
@NP	We	41882
@NP	no evidence	41896
@NP	regeneration of ascending central branches of sensory axons from L3-L6 DRG	41912
@NP	regeneration	41912
@NP	central branches of sensory axons	41938
@NP	central branches	41938
@NP	sensory axons	41958
@NP	L3-L6 DRG	41977
@NP	This result	41988
@NP	previouswork	42019
@NP	this laboratory	42037
@NP	13 -RSB-	42054
@NP	very few sensory axons whose cell bodies lie in L3-L6 DRG	42077
@NP	very few sensory axons	42077
@NP	cell bodies	42106
@NP	L3-L6 DRG	42125
@NP	the CTB injection	42158
@NP	axons	42184
@NP	SC bridges placed at T8-T10 one month previously	42195
@NP	SC bridges	42195
@NP	T8-T10 one month	42216
@NP	T8-T10	42216
@NP	one month	42223
@NP	the lack	42251
@NP	evidence for regrowth of serotonergic fibers or dorsal column sensory axons	42263
@NP	evidence	42263
@NP	regrowth of serotonergic fibers or dorsal column sensory axons	42276
@NP	regrowth	42276
@NP	serotonergic fibers or dorsal column sensory axons	42288
@NP	other mechanisms	42340
@NP	the recovery of hindlimb movements	42370
@NP	the recovery	42370
@NP	hindlimb movements	42386
@NP	BH and MEH rats	42408
@NP	It	42425
@NP	fiber tracts	42445
@NP	those examined in the present study -LRB- e.g. reticulospinal axons -RRB-	42469
@NP	those	42469
@NP	the present study -LRB- e.g. reticulospinal axons -RRB-	42487
@NP	the present study	42487
@NP	e.g. reticulospinal axons	42506
@NP	e.g.	42506
@NP	reticulospinal axons	42511
@NP	the site of transection	42552
@NP	the site	42552
@NP	transection	42564
@NP	distal cord	42593
@NP	It	42606
@NP	improvements in hindlimbmovement	42645
@NP	improvements	42645
@NP	hindlimbmovement	42661
@NP	axon regeneration across the injury site	42698
@NP	axon regeneration	42698
@NP	the injury site	42723
@NP	changes in circuitry	42756
@NP	changes	42756
@NP	circuitry	42767
@NP	the level of transection	42783
@NP	the level	42783
@NP	transection	42796
@NP	This	42809
@NP	compensatory plasticity of networks	42828
@NP	compensatory plasticity	42828
@NP	networks	42855
@NP	the lumbar spinal cord such as modulation of existing synaptic connections	42867
@NP	the lumbar spinal cord	42867
@NP	modulation of existing synaptic connections	42898
@NP	modulation	42898
@NP	existing synaptic connections	42912
@NP	example	42947
@NP	transection in rats and mice	42962
@NP	transection	42962
@NP	rats and mice	42977
@NP	pharmacological or electrophysiological stimulation	42992
@NP	partial	43055
@NP	treadmills	43092
@NP	the absence	43106
@NP	regeneration of descending or ascending fiber tracts -LSB- 28,36 -RSB-	43121
@NP	regeneration	43121
@NP	fiber tracts	43161
@NP	28,36 -RSB-	43175
@NP	Transplanted SCs or OEG	43183
@NP	15 -RSB- and factors secreted by grafts	43228
@NP	15 -RSB- and factors	43228
@NP	grafts	43256
@NP	function	43279
@NP	spared circuits	43291
@NP	the spinal cord caudal to the transection such as the central pattern generator	43310
@NP	the spinal cord caudal	43310
@NP	the transection such as the central pattern generator	43336
@NP	the transection	43336
@NP	the central pattern generator	43360
@NP	We	43391
@NP	function recovered in BH and MEH rats	43411
@NP	function	43411
@NP	BH and MEH rats	43433
@NP	MEH rats due to regenerated axons	43466
@NP	MEH rats	43466
@NP	regenerated axons	43482
@NP	circuitries	43519
@NP	sensory stimulation	43567
@NP	motor activity	43594
@NP	Our study	43610
@NP	housing rats in stimulating environments	43631
@NP	housing rats	43631
@NP	environments	43659
@NP	a number of benefits	43680
@NP	a number	43680
@NP	benefits	43692
@NP	The loss of restored function in rats in long-term -LRB- > two months -RRB- BH	43702
@NP	The loss	43702
@NP	restored function in rats in long-term -LRB- > two months -RRB- BH	43714
@NP	restored function	43714
@NP	rats in long-term -LRB- > two months -RRB- BH	43735
@NP	rats	43735
@NP	long-term -LRB- > two months -RRB- BH	43743
@NP	> two months	43754
@NP	>	43754
@NP	two months	43756
@NP	`` standard '' plexiglas cages	43784
@NP	`` standard '' plexiglas	43784
@NP	cages	43805
@NP	`` sub-standard '' or `` impoverished ''	43839
@NP	`` enriched environmentsn ''	43881
@NP	basic housing	43931
@NP	It	43947
@NP	decades	43969
@NP	rats of social contact	43992
@NP	rats	43992
@NP	social contact	44000
@NP	other rats	44020
@NP	physiological and behavioral abnormalities	44040
@NP	39 -RSB-	44084
@NP	More recent studies	44089
@NP	impoverished environments	44125
@NP	recovery	44158
@NP	brain injury -LSB- 40,41 -RSB-	44173
@NP	brain injury	44173
@NP	40,41 -RSB-	44187
@NP	gait characteristics	44205
@NP	intact rats -LSB- 42 -RSB-	44229
@NP	intact rats	44229
@NP	42 -RSB-	44242
@NP	Our study	44247
@NP	a small degree of hindlimb function	44268
@NP	a small degree	44268
@NP	hindlimb function	44286
@NP	rats housed in BH comparable to that recovered by rats in MEH	44321
@NP	rats	44321
@NP	BH	44336
@NP	that recovered by rats in MEH	44353
@NP	that	44353
@NP	rats in MEH	44371
@NP	rats	44371
@NP	MEH	44379
@NP	BH housing	44393
@NP	reduced BBB scores	44411
@NP	Our study	44439
@NP	yet more evidence	44463
@NP	single housing of rats in cages devoid of enrichment opportunities	44486
@NP	single housing	44486
@NP	rats in cages devoid of enrichment opportunities	44504
@NP	rats	44504
@NP	cages devoid of enrichment opportunities	44512
@NP	cages	44512
@NP	enrichment opportunities	44528
@NP	the laboratory setting	44572
@NP	studies	44613
@NP	functional recovery	44632
@NP	injury	44658
@NP	the CNS	44668
@NP	It	44677
@NP	the progressive detrimental effect upon restored function	44711
@NP	the progressive detrimental effect	44711
@NP	restored function	44751
@NP	more than two months	44775
@NP	the need to monitor recovery for more than just one or two months	44822
@NP	recovery	44842
@NP	more than just one or two months	44855
@NP	more than just	44855
@NP	one or two months	44870
@NP	our knowledge	44892
@NP	this study	44907
@NP	glial cell transplantation	44942
@NP	complete transection injury with motor enrichment	44979
@NP	complete transection injury	44979
@NP	motor enrichment	45012
@NP	Other studies	45030
@NP	beneficial effects of exposure	45062
@NP	beneficial effects	45062
@NP	exposure	45084
@NP	motor therapy and environmental enrichment	45105
@NP	motor therapy	45105
@NP	environmental enrichment	45123
@NP	other models of brain or spinal cord injury -LSB- 1 -- 6,43 -- 46 -RSB-	45151
@NP	other models	45151
@NP	brain or spinal cord injury -LSB- 1 -- 6,43 -- 46 -RSB-	45167
@NP	brain	45167
@NP	spinal cord injury -LSB- 1	45176
@NP	spinal cord injury	45176
@NP	1	45196
@NP	6,43	45198
@NP	46 -RSB-	45203
@NP	Our results	45208
@NP	the notion	45236
@NP	recovery of function	45252
@NP	recovery	45252
@NP	function	45264
@NP	locomotor activity	45288
@NP	it	45330
@NP	environmental enrichment	45353
@NP	symptom onset	45388
@NP	neurodegenerative disease -LSB- 47 -RSB-	45405
@NP	neurodegenerative disease	45405
@NP	47 -RSB-	45432
@NP	reverse aging-associated neurodegenerative events -LSB- 48 -RSB-	45448
@NP	reverse aging-associated neurodegenerative events	45448
@NP	48 -RSB-	45499
@NP	the present work	45504
@NP	the first study	45524
@NP	we	45545
@NP	post-operative enrichment	45570
@NP	progressive loss of restored hindlimb movement	45608
@NP	progressive loss	45608
@NP	restored hindlimb movement	45628
@NP	sum	45659
@NP	our study	45664
@NP	long-term maintenance in deprived circumstances	45692
@NP	long-term maintenance	45692
@NP	deprived circumstances	45717
@NP	progressive loss of residual or restored function	45752
@NP	progressive loss	45752
@NP	residual or restored function	45772
@NP	residual	45772
@NP	restored function	45784
@NP	opportunities for self-rehabilitation and social interaction	45811
@NP	opportunities	45811
@NP	self-rehabilitation and social interaction	45829
@NP	recovered function	45884
@NP	spinal transection and acute glial cell transplantation	45913
@NP	spinal transection	45913
@NP	acute glial cell transplantation	45936
@NP	More work	45970
@NP	More	45970
@NP	the conditions under which motor rehabilitation	46011
@NP	conditions	46015
@NP	transplantion ofOEG and SCs	46066
@NP	significant benefit	46107
@NP	humans	46130
@NP	the interim	46141
@NP	our results	46154
@NP	spinal cord injured persons	46179
@NP	spinal cord	46179
@NP	persons	46199
@NP	rehabilitation opportunities	46239
@NP	overall health	46282
@NP	residual function	46326
@VP	recovered after spinal cord injury and glial transplantation L.D.F.	45
@VP	containing ramps , textured surfaces and rewards	1040
@VP	starting one week postsurgery	1146
@VP	comparing rats housed in MEH to those in basic housing -LRB- BH -RRB-	1177
@VP	housed in MEH to those in basic housing -LRB- BH -RRB-	1192
@VP	allowing sensory axons in the dorsal columns to be visualized by immunolabeling	1342
@VP	to be visualized by immunolabeling	1387
@VP	be visualized by immunolabeling	1390
@VP	visualized by immunolabeling	1393
@VP	expressing low affinity nerve	1458
@VP	were identified by immunolabeling	1511
@VP	identified by immunolabeling	1516
@VP	having received transplants	1566
@VP	received transplants	1573
@VP	recovered some hindlimb movement	1595
@VP	housed in BH	1634
@VP	recovered hindlimb movements	1702
@VP	were sustained in most rats in MEH	1731
@VP	sustained in most rats in MEH	1736
@VP	transplanted with SCs and OEG	1775
@VP	were first significant 14 weeks after injury	1821
@VP	transplanted with OEG	1875
@VP	was seen from 14 weeks after injury	1906
@VP	seen from 14 weeks after injury	1910
@VP	did not reach significance	1952
@VP	reach significance	1960
@VP	died back from sites of transplantation and did not regenerate rostrally	2014
@VP	died back from sites of transplantation	2014
@VP	did not regenerate rostrally	2058
@VP	regenerate rostrally	2066
@VP	observed regenerating into	2131
@VP	regenerating into	2140
@VP	induced recovery of hindlimb function	2252
@VP	recovered hindlimb movement was sustained in rats housed in MEH	2296
@VP	was sustained in rats housed in MEH	2324
@VP	sustained in rats housed in MEH	2328
@VP	housed in MEH	2346
@VP	was progressively lost in rats housed in BH	2364
@VP	progressively lost in rats housed in BH	2368
@VP	housed in BH	2395
@VP	were not observed until 14 weeks after injury	2433
@VP	observed until 14 weeks after injury	2442
@VP	is recommended	2513
@VP	recommended	2516
@VP	are not conducive to maintenance of recovered hindlimb function	2543
@VP	should be used in studies of recovery of function following spinal cord injury	2616
@VP	be used in studies of recovery of function following spinal cord injury	2623
@VP	used in studies of recovery of function following spinal cord injury	2626
@VP	1	2697
@VP	will likely require multiple interventions	2768
@VP	require multiple interventions	2780
@VP	have proven more powerful than single treatments alone	2869
@VP	proven more powerful than single treatments alone	2874
@VP	is attractive as a component of combination therapy for SCI repair	2943
@VP	supporting the benefits of exercise and rehabilitation following SCI	3020
@VP	is accumulating -LSB- 1 -- 8 -RSB-	3089
@VP	accumulating -LSB- 1 -- 8 -RSB-	3092
@VP	extend axons into grafts of purified rat or human SCs -LSB- 9 -- 13 -RSB-	3338
@VP	enhance axonal growth -LSB- 14 -RSB-	3444
@VP	can be obtained readily for autotransplantation	3489
@VP	be obtained readily for autotransplantation	3493
@VP	obtained readily for autotransplantation	3496
@VP	are neuroprotective after contusion injury -LSB- 15 -RSB-	3541
@VP	may have improved recovery following transection and transplantation	3976
@VP	have improved recovery following transection and transplantation	3980
@VP	improves outcome following SCI	4098
@VP	to determine whether the combined effect would enhance functional recovery	4183
@VP	determine whether the combined effect would enhance functional recovery	4186
@VP	would enhance functional recovery	4224
@VP	enhance functional recovery	4230
@VP	are extremely labor-intensive to conduct	4295
@VP	to conduct	4325
@VP	conduct	4328
@VP	participate according to individual ability and motivation	4478
@VP	housed individually in basic housing -LRB- BH -RRB- conditions	4630
@VP	2	4685
@VP	weighing 160 -- 192 g , approximately 3 months of age	4833
@VP	described below	4961
@VP	were housed in a 12 h : 12 h light : dark cycle	5015
@VP	housed in a 12 h : 12 h light : dark cycle	5020
@VP	was obtained from the University of Miami Animal Care and Use Committee	5069
@VP	obtained from the University of Miami Animal Care and Use Committee	5073
@VP	-LRB- 95 -- 98 % -RRB- from sciatic nerves	5201
@VP	described previously -LSB- 20 -RSB-	5251
@VP	divested of perineurium	5355
@VP	cultured on plastic to allow outgrowth of fibroblasts	5383
@VP	to allow outgrowth of fibroblasts	5403
@VP	allow outgrowth of fibroblasts	5406
@VP	dissociated enzymatically	5450
@VP	expressing Thy1 .1	5762
@VP	were also depleted by immunopanning	5780
@VP	depleted by immunopanning	5790
@VP	re-plating after confluency three times	5823
@VP	containing 0.1 % gentamycin , Invitrogen	5938
@VP	were cut into 3 mm lengths	6353
@VP	cut into 3 mm lengths	6358
@VP	was pipetted into each open end	6458
@VP	pipetted into each open end	6462
@VP	incubating at 37 ◦ C for ten minutes to allow gelling	6546
@VP	to allow gelling	6581
@VP	allow gelling	6584
@VP	containing 6 % carbon dioxide	6670
@VP	measuring 2 mm in length and 2.7 mm in diameter	6708
@VP	described previously -LSB- 15 -RSB-	7009
@VP	dissected from donor adult female Fischer rats	7066
@VP	dissociated enzymatically	7114
@VP	expanded as for SCs -LRB- except without using heregulin -RRB-	7144
@VP	using heregulin	7180
@VP	were selected by immunopanning	7250
@VP	selected by immunopanning	7255
@VP	were suspended in 4 μl of transplant medium -LRB- see above -RRB-	7344
@VP	suspended in 4 μl of transplant medium -LRB- see above -RRB-	7349
@VP	see above	7389
@VP	shown schematically in Fig. 1	7489
@VP	was shaved and painted with 70 % ethanol and betadine	7807
@VP	shaved and painted with 70 % ethanol and betadine	7811
@VP	was applied to the eyes to prevent drying	7931
@VP	applied to the eyes to prevent drying	7935
@VP	to prevent drying	7955
@VP	prevent drying	7958
@VP	drying	7966
@VP	was made along the thoracic vertebrae and skin	7993
@VP	made along the thoracic vertebrae and skin	7997
@VP	were retracted	8064
@VP	retracted	8069
@VP	were removed	8129
@VP	removed	8134
@VP	was incised at the dorsal midline	8152
@VP	incised at the dorsal midline	8156
@VP	was applied for 15 seconds	8249
@VP	applied for 15 seconds	8253
@VP	was transected using angled microscissors	8319
@VP	transected using angled microscissors	8323
@VP	using angled microscissors	8334
@VP	was transected a second time caudally	8371
@VP	transected a second time caudally	8375
@VP	was removed , creating a 2-mm gap centered in T10	8424
@VP	removed , creating a 2-mm gap centered in T10	8428
@VP	creating a 2-mm gap centered in T10	8437
@VP	centered in T10	8457
@VP	prepared as described above	8487
@VP	described above	8499
@VP	was implanted into the gap to appose the stumps -LRB- Fig. 1A -RRB-	8516
@VP	implanted into the gap to appose the stumps -LRB- Fig. 1A -RRB-	8520
@VP	to appose the stumps -LRB- Fig. 1A -RRB-	8543
@VP	appose the stumps -LRB- Fig. 1A -RRB-	8546
@VP	attached to a 1-μl syringe -LRB- Hamilton , Reno , NV -RRB-	8637
@VP	mounted on a stereotaxic micromanipulator	8684
@VP	was immobilized	8745
@VP	immobilized	8749
@VP	to give a total of 200,000 cells per stump	8913
@VP	give a total of 200,000 cells per stump	8916
@VP	allowed to elapse to reduce reflux of cells on withdrawal of the micropipette	8974
@VP	to elapse to reduce reflux of cells on withdrawal of the micropipette	8982
@VP	elapse to reduce reflux of cells on withdrawal of the micropipette	8985
@VP	to reduce reflux of cells on withdrawal of the micropipette	8992
@VP	reduce reflux of cells on withdrawal of the micropipette	8995
@VP	was left in place above the injection site	9078
@VP	left in place above the injection site	9082
@VP	was transected	9171
@VP	transected	9175
@VP	was taken to transect all ventral and lateral tissues , including the dura	9192
@VP	taken to transect all ventral and lateral tissues , including the dura	9196
@VP	to transect all ventral and lateral tissues , including the dura	9202
@VP	transect all ventral and lateral tissues , including the dura	9205
@VP	were not lifted to confirm completeness of transection	9274
@VP	lifted to confirm completeness of transection	9283
@VP	to confirm completeness of transection	9290
@VP	confirm completeness of transection	9293
@VP	retracted slightly	9351
@VP	were injected into the cord stumps as described above -LRB- Fig. 1B -RRB-	9375
@VP	injected into the cord stumps as described above -LRB- Fig. 1B -RRB-	9380
@VP	stumps as described above -LRB- Fig. 1B -RRB-	9403
@VP	described above -LRB- Fig. 1B -RRB-	9413
@VP	placed on the site of transection	9478
@VP	grafting to prevent adherence of the overlying tissues after suturing	9516
@VP	to prevent adherence of the overlying tissues after suturing	9525
@VP	prevent adherence of the overlying tissues after suturing	9528
@VP	suturing	9577
@VP	were sutured closed	9601
@VP	sutured closed	9606
@VP	closed	9614
@VP	was painted with antiseptic -LRB- 3 % hydrogen peroxide -RRB-	9631
@VP	painted with antiseptic -LRB- 3 % hydrogen peroxide -RRB-	9635
@VP	were removed 10 days after surgery	9751
@VP	removed 10 days after surgery	9756
@VP	was given to prevent dehydration	9813
@VP	given to prevent dehydration	9817
@VP	to prevent dehydration	9823
@VP	prevent dehydration	9826
@VP	containing 160 mg/kg body weight , p.o.	9946
@VP	containing 30 mg/kg body weight , s.c.	10129
@VP	were expressed manually twice daily until automatic voiding began	10178
@VP	expressed manually twice daily until automatic voiding began	10183
@VP	began	10238
@VP	placed on heating pads -LRB- 37 ◦ C -RRB- with water and food	10531
@VP	placed within cages for easy access	10581
@VP	was placed on cage floors	10673
@VP	placed on cage floors	10677
@VP	were changed twice weekly	10706
@VP	changed twice weekly	10711
@VP	survived one week post-surgery	10743
@VP	were no differences between BH	10875
@VP	were no differences in locomotor performance between groups at this time	11044
@VP	measuring 17 long	11185
@VP	were housed individually	11327
@VP	housed individually	11332
@VP	distributed by www.theferretstore.com	11452
@VP	measured 36 long , 24 wide and 48 high	11507
@VP	had a smooth plastic floor with two upper plastic shelves	11552
@VP	were made of 11-gauge wire -LRB- 15/16 × 6 1/16 -RRB-	11622
@VP	made of 11-gauge wire -LRB- 15/16 × 6 1/16 -RRB-	11627
@VP	to improve function in rats with severe traumatic brain injury -LSB- 21 -RSB-	11716
@VP	improve function in rats with severe traumatic brain injury -LSB- 21 -RSB-	11719
@VP	to provide an environment where rats were encouraged to move freely , vigorously	11828
@VP	provide an environment where rats were encouraged to move freely , vigorously	11831
@VP	were encouraged to move freely , vigorously	11865
@VP	encouraged to move freely , vigorously	11870
@VP	to move freely , vigorously	11881
@VP	move freely , vigorously	11884
@VP	shown to be detrimental to recovery in several models of CNS injury -LSB- 22	12014
@VP	to be detrimental to recovery in several models of CNS injury -LSB- 22	12020
@VP	be detrimental to recovery in several models of CNS injury -LSB- 22	12023
@VP	alternating movements	12257
@VP	stepping	12343
@VP	were set at angles of approximately 35 degrees above the horizontal	12384
@VP	set at angles of approximately 35 degrees above the horizontal	12389
@VP	were placed on the ground floor	12546
@VP	placed on the ground floor	12551
@VP	were seen to remain fully extended during use	12644
@VP	seen to remain fully extended during use	12649
@VP	to remain fully extended during use	12654
@VP	remain fully extended during use	12657
@VP	fully extended during use	12664
@VP	consisting of wire grid	12741
@VP	to reinforce observed improvements in hindpaw movements	12808
@VP	reinforce observed improvements in hindpaw movements	12811
@VP	observed improvements in hindpaw movements	12821
@VP	Placing bedding -LRB- crumpled paper towels -RRB-	12865
@VP	treats	12909
@VP	daily on the upper levels motivated rats to explore	12941
@VP	to explore	12982
@VP	explore	12985
@VP	to encourage climbing of wire walls	13139
@VP	encourage climbing of wire walls	13142
@VP	placed at opposite sides of the ground floor , thereby encouragingmovement	13196
@VP	allowing ad libitum access	13274
@VP	were housed in groups of up to 12	13307
@VP	housed in groups of up to 12	13312
@VP	designed to encourage and reinforce any hindlimb movements	13482
@VP	to encourage and reinforce any hindlimb movements	13491
@VP	encourage and reinforce any hindlimb movements	13494
@VP	were obtained in the nocturnal cycle when rats are most active	13565
@VP	obtained in the nocturnal cycle when rats are most active	13570
@VP	are most active	13612
@VP	were kept in the same room as rats housed in MEH	13648
@VP	kept in the same room as rats housed in MEH	13653
@VP	housed in MEH	13683
@VP	were exposed to the same light , humidity and temperature conditions	13702
@VP	exposed to the same light , humidity and temperature conditions	13707
@VP	handled regularly and given treats when the rats housed in MEH were given treats	13784
@VP	handled regularly	13784
@VP	given treats when the rats housed in MEH were given treats	13806
@VP	treats when the rats housed in MEH were given	13812
@VP	housed in MEH	13833
@VP	were given	13847
@VP	given	13852
@VP	treats	13858
@VP	using the BBB open-field test rating scale -LSB- 26 -RSB-	13914
@VP	to treat ment groups	13986
@VP	treat ment groups	13989
@VP	beginning one week following transection / grafting	14058
@VP	beginning one week following transection	14058
@VP	grafting	14100
@VP	survived until the end of the experiment	14132
@VP	were included for analysis	14173
@VP	included for analysis	14178
@VP	injected after the last BBB test and three days before the end of the experiment	14331
@VP	was shaved and painted with antiseptic	14507
@VP	shaved and painted with antiseptic	14511
@VP	was exposed at midthigh level	14569
@VP	exposed at midthigh level	14573
@VP	was crushed for 10 seconds using forceps	14610
@VP	crushed for 10 seconds using forceps	14614
@VP	using forceps	14637
@VP	were injected proximal to the crush	14741
@VP	injected proximal to the crush	14746
@VP	was withdrawn	14821
@VP	withdrawn	14825
@VP	was ligated distally	14849
@VP	ligated distally	14853
@VP	buffered saline -LRB- PBS -RRB- and then with 500 ml 4 % paraformaldehyde in PBS	15003
@VP	immersing for at least	15149
@VP	cut onto coated slides -LRB- Snowcoat X-tra , Surgipath , Richmond , IL -RRB-	15360
@VP	were stored at − 20	15429
@VP	stored at − 20	15434
@VP	were thawed and airdried fully prior to immunolabeling	15627
@VP	thawed and airdried fully prior to immunolabeling	15632
@VP	was immunoperoxidaselabeled for CTB	15706
@VP	immunoperoxidaselabeled for CTB	15710
@VP	incubating sections for 30 minutes in 3 % hydrogen peroxide and 10 % methanol	15906
@VP	containing 5 % heat-treated normal rabbit serum	16041
@VP	containing goat-anti CTB -LRB- 1:20,000 , List Biologicals -RRB- and 5 % NRS	16175
@VP	washed	16255
@VP	biotinylated rabbit anti-goat IgG -LRB- 1:200 , Vector -RRB- and 5 % NRS	16313
@VP	washed	16389
@VP	washed twice in TBS and twice in 50 mM Tris-HCl -LRB- TNS -RRB-	16528
@VP	washed twice in TBS	16528
@VP	twice in 50 mM Tris-HCl -LRB- TNS -RRB-	16552
@VP	containing 5 mMsodium acetate and 13 mg cresyl violet	16781
@VP	washing with distilled water	16861
@VP	dehydrating through alcohols	16891
@VP	coverslipping using Sub-X -LRB- Surgipath -RRB-	16924
@VP	using Sub-X -LRB- Surgipath -RRB-	16938
@VP	was immunofluorescence labeled for serotonin and p75	16991
@VP	labeled for serotonin and p75	17014
@VP	were re-hydrated using 0.2 % TXTBS	17054
@VP	using 0.2 % TXTBS	17071
@VP	containing 10 % heat-inactivated normal goat serum	17127
@VP	incubated for five hours in TBS containing goat anti-rabbit IgG	17356
@VP	containing goat anti-rabbit IgG	17388
@VP	were washed and blocked as before	17504
@VP	washed and blocked as before	17509
@VP	supplied by Dr.	17656
@VP	Louis , MO -RRB- containing 5 % NGS and 0.1 % Tween-20	17715
@VP	containing 5 % NGS and 0.1 % Tween-20	17726
@VP	washed	17777
@VP	conjugated to Alexa 488 -LRB- 1:200 , Molecular Probes -RRB- and bisbenzimide	17855
@VP	washed in PBS , air-dried	17937
@VP	coverslipped using Vectamount -LRB- Vector Laboratories -RRB-	17966
@VP	using Vectamount -LRB- Vector Laboratories -RRB-	17979
@VP	was taken for plastic embedding	18159
@VP	taken for plastic embedding	18163
@VP	To maximize use of available tissue	18192
@VP	maximize use of available tissue	18195
@VP	were terminally anesthetized	18274
@VP	died from complications prior to the end of the experiment	18306
@VP	used for identifying myelinated axons	18392
@VP	identifying myelinated axons	18401
@VP	not for the other histology described above	18435
@VP	survived the full study and were perfusion fixed under terminal anaesthesia	18546
@VP	survived the full study	18546
@VP	were perfusion fixed under terminal anaesthesia	18574
@VP	fixed under terminal anaesthesia	18589
@VP	were stained with toluidine blue -LSB- 10 -RSB-	18796
@VP	stained with toluidine blue -LSB- 10 -RSB-	18801
@VP	to recognize peripheral-type myelin in plastic cross sections	18848
@VP	recognize peripheral-type myelin in plastic cross sections	18851
@VP	is caused by the formation of extracellular matrix	19065
@VP	caused by the formation of extracellular matrix	19068
@VP	do not exhibit adjacent nuclei	19159
@VP	exhibit adjacent nuclei	19166
@VP	have little or no space between them -LSB- 15 -RSB-	19194
@VP	using DEPEX -LRB- Electron Microscopy Sciences , Fort Washington , PA -RRB-	19264
@VP	photographed -LRB- Axiovert , Zeiss -RRB-	19332
@VP	involved in the OEG groups	19487
@VP	containing SCs	19673
@VP	is a factor in these experiments	19715
@VP	taking each injury type separately -LRB- p = 0.05 -RRB-	19865
@VP	identify the time at which differences between groups first became significant	19915
@VP	became significant	19975
@VP	using Bonferroni 's correction for multiple comparisons -LRB- p < 0.005 -RRB-	20090
@VP	yielded p < 0.05 for most comparisons	20236
@VP	were examined using Pearson 's Chi square test -LRB- p = 0.05 -RRB-	20350
@VP	examined using Pearson 's Chi square test -LRB- p = 0.05 -RRB-	20355
@VP	using Pearson 's Chi square test -LRB- p = 0.05 -RRB-	20364
@VP	crawling	20490
@VP	examined using Fisher 's exact test for 2 × 2 comparisons -LRB- p = 0.05 -RRB-	20504
@VP	using Fisher 's exact test for 2 × 2 comparisons -LRB- p = 0.05 -RRB-	20513
@VP	were performed using SPSS -LRB- SPSS Inc. , Chicago , IL -RRB-	20594
@VP	performed using SPSS -LRB- SPSS Inc. , Chicago , IL -RRB-	20599
@VP	using SPSS -LRB- SPSS Inc. , Chicago , IL -RRB-	20609
@VP	3	20647
@VP	depicting the two types of surgical intervention	20676
@VP	was created	20794
@VP	created	20798
@VP	was implanted with injection of OEG into the stumps	20822
@VP	implanted with injection of OEG into the stumps	20826
@VP	were injected into the stumps without accompanying SC bridge implantation	20883
@VP	injected into the stumps without accompanying SC bridge implantation	20888
@VP	were maintained postoperatively in one of two different types of housing	20972
@VP	maintained postoperatively in one of two different types of housing	20977
@VP	recovered a small degree of hindlimb function	21190
@VP	was only maintained in groups of rats housed in motor enriched environments	21250
@VP	maintained in groups of rats housed in motor enriched environments	21259
@VP	housed in motor enriched environments	21288
@VP	transplanted only with OEG	21486
@VP	transplanted with SCs and OEG	21531
@VP	indicate statistically significant differences between groups at a given time	21572
@VP	are very small for the SC/OEG/MEH group as it had largest number of rats	21662
@VP	had largest number of rats	21708
@VP	myelinated axons	21775
@VP	were present in SC bridges	21792
@VP	taken from a SC/OEG rat that survived 12 weeks in MEH	21906
@VP	survived 12 weeks in MEH	21935
@VP	illustrates peripherally myelinated axons throughout the graft	21969
@VP	peripherally myelinated axons throughout the graft	21981
@VP	are also present -LRB- asterisks -RRB-	22047
@VP	bar = 25 μm	22083
@VP	= 25 μm	22087
@VP	illustrates myelinated axons from the box in A shown at higher magnification	22104
@VP	is seen adjacent to the myelin , an identifying feature of SC-formed myelin	22211
@VP	seen adjacent to the myelin , an identifying feature of SC-formed myelin	22214
@VP	bar = 5 μm	22293
@VP	= 5 μm	22297
@VP	Ascending central branches of sensory axons from lumbar DRG	22314
@VP	counterstained with cresyl violet -LRB- blue -RRB-	22553
@VP	taken from a SC/OEG/MEH rat at 22 weeks	22595
@VP	is 500 um to the left side of the figure	22680
@VP	is shown	22755
@VP	shown	22758
@VP	die back 1 mm from the site of injury and have not regenerated rostrally	22783
@VP	die back 1 mm from the site of injury	22783
@VP	have not regenerated rostrally	22825
@VP	regenerated rostrally	22834
@VP	bar = 100 μm	22863
@VP	= 100 μm	22867
@VP	showing retraction bulbs -LRB- arrows -RRB- at higher magnification	22918
@VP	bar = 100 μm	22983
@VP	= 100 μm	22987
@VP	taken from OEG/BH rats , 22 weeks postsurgery	23237
@VP	indicates approximate level of transection	23419
@VP	indicates approximate level of injection of OEG	23476
@VP	bar = 500 μm	23531
@VP	= 500 μm	23535
@VP	boxed in -LRB- A -RRB-	23580
@VP	were only rarely associated with p75-immunoreactive cells	23613
@VP	rarely associated with p75-immunoreactive cells	23623
@VP	bar = 100 μm	23678
@VP	= 100 μm	23682
@VP	failed to extend into transplant sites	23853
@VP	to extend into transplant sites	23860
@VP	extend into transplant sites	23863
@VP	bar = 100 μm	23899
@VP	= 100 μm	23903
@VP	died in BH whereas 2 of 9 died in MEH	23967
@VP	died in MEH	23993
@VP	died , whereas 1 of 11 in MEH died	24051
@VP	died	24080
@VP	sided p = 0.128	24186
@VP	died after being transferred to BH or MEH	24226
@VP	being transferred to BH or MEH	24237
@VP	transferred to BH or MEH	24243
@VP	died when housed in BH -LRB- n = 6 -RRB- as in MEH -LRB- n = 3 -RRB-	24283
@VP	housed in BH -LRB- n = 6 -RRB- as in MEH -LRB- n = 3 -RRB-	24293
@VP	was not significant -LRB- Fisher 's exact test , one-tailed , p = 0.17 -RRB-	24359
@VP	died	24441
@VP	had received OEG transplants and 2 had received SC/OEG transplants	24449
@VP	received OEG transplants and 2 had received SC/OEG transplants	24453
@VP	had received SC/OEG transplants	24484
@VP	received SC/OEG transplants	24488
@VP	was not significant -LRB- Fisher 's exact test , two-sided , p = 0.124 -RRB-	24533
@VP	were often sedentary throughout the 22-week survival period	24647
@VP	housed in MEH	24726
@VP	were highly active throughout the 22-week experiment	24740
@VP	illustrating these behaviours	24809
@VP	are available on request from L.M.	24839
@VP	prevented measurement of individual activity	24912
@VP	to climb ramps and the wire walls , as well as to climb over and through tunnels	25025
@VP	to climb ramps and the wire walls	25025
@VP	climb ramps and the wire walls	25028
@VP	to climb over and through tunnels	25071
@VP	climb over and through tunnels	25074
@VP	served as an indirect measure of cage activity	25185
@VP	motivated to climb to the second and third cage levels throughout the study	25274
@VP	to climb to the second and third cage levels throughout the study	25284
@VP	climb to the second and third cage levels throughout the study	25287
@VP	did not become trapped in the rungs of the wheels or ramps	25369
@VP	become trapped in the rungs of the wheels or ramps	25377
@VP	trapped in the rungs of the wheels or ramps	25384
@VP	were dragged behind the rats but were not entirely flaccid	25439
@VP	were dragged behind the rats	25439
@VP	dragged behind the rats	25444
@VP	were not entirely flaccid	25472
@VP	whenmoving over textured ramps	25578
@VP	chose to sleep on the ground floor in groups of ten to twelve	25625
@VP	to sleep on the ground floor in groups of ten to twelve	25631
@VP	sleep on the ground floor in groups of ten to twelve	25634
@VP	demonstrated some return of hindlimb joint movement after the spinal injury	26450
@VP	survived 22 weeks post-surgery	26644
@VP	depicts the SC/OEG trans planted groups	26734
@VP	planted groups	26759
@VP	exhibited mean scores below one	26809
@VP	-LSB- 26	26997
@VP	housed in MEH	27042
@VP	was true only for 80 % of OEG/BH and 29 % of SC/OEG/BH rats	27108
@VP	equal to or greater	27252
@VP	attained mean hindlimb scores above eight	27419
@VP	obtained peak mean hindlimb scores of nine and one OEG/MEH rat obtained 10.5	27497
@VP	obtained 10.5	27560
@VP	obtained a score of nine or more from three to 22 weeks post-surgery	27613
@VP	indicate that transectionwas complete in this rat	27709
@VP	was 1.0	27973
@VP	sparing	28024
@VP	see below	28084
@VP	were significant	28168
@VP	were conducted from 13 to 22 weeks postinjury inclusive	28205
@VP	conducted from 13 to 22 weeks postinjury inclusive	28210
@VP	were used -LRB- p < 0.005 -RRB-	28413
@VP	used -LRB- p < 0.005 -RRB-	28418
@VP	were detected between BH and MEH in rats transplanted with SC/OEG at weeks 14	28448
@VP	detected between BH and MEH in rats transplanted with SC/OEG at weeks 14	28453
@VP	were observed at weeks 19 and 20 -LRB- p = 0.013 and 0.0059 , respectively -RRB-	28548
@VP	observed at weeks 19 and 20 -LRB- p = 0.013 and 0.0059 , respectively -RRB-	28553
@VP	± SEM	28664
@VP	were 8.0 ± 0.0 for SC/OEG/MEH versus 4.6 ± 0.8 for SC/OEG/BH	28670
@VP	mean scores were 6.0 ± 0.5 for SC/OEG/MEH versus 4.9 ± 0.5 for SC/OEG/BH	28764
@VP	were 6.0 ± 0.5 for SC/OEG/MEH versus 4.9 ± 0.5 for SC/OEG/BH	28776
@VP	recovered hindlimb function from 14 weeks	28973
@VP	is maintained for rats in MEH , at least until 21 weeks	29041
@VP	maintained for rats in MEH , at least until 21 weeks	29044
@VP	were used -LRB- p < 0.005 -RRB-	29134
@VP	used -LRB- p < 0.005 -RRB-	29139
@VP	exceeded those for BH	29408
@VP	are adjusted using Bonferroni 's correction	29505
@VP	adjusted using Bonferroni 's correction	29509
@VP	using Bonferroni 's correction	29518
@VP	± SEM	29595
@VP	were 8.4 ± 0.5 for OEG/MEH versus 6.9 ± 0.4 for OEG/BH	29602
@VP	mean scores were 7.8 ± 0.3 for OEG/MEH versus 5.4 ± 0.8 for OEG/BH	29689
@VP	were 7.8 ± 0.3 for OEG/MEH versus 5.4 ± 0.8 for OEG/BH	29701
@VP	recover hindlimb function in both types of housing -LRB- BH and MEH -RRB-	29791
@VP	lose function over time	29893
@VP	could not be detected at any specific timepoint	29946
@VP	be detected at any specific timepoint	29956
@VP	detected at any specific timepoint	29959
@VP	crawling	30080
@VP	is not represented within the BBB rating scale	30115
@VP	represented within the BBB rating scale	30122
@VP	being supported on the knee joints throughout	30291
@VP	supported on the knee joints throughout	30297
@VP	illustrating this behaviour	30354
@VP	is available on request from L.M.	30382
@VP	was first noted in rats nine weeks after injury	30425
@VP	noted in rats nine weeks after injury	30435
@VP	established , crawling	30479
@VP	crawling	30492
@VP	was stable	30501
@VP	exhibited crawling usually	30529
@VP	crawling usually	30539
@VP	exhibited instances of crawling in all BBB testing sessions thereafter	30556
@VP	crawling in all BBB testing sessions thereafter	30579
@VP	housed in MEH	30651
@VP	crawling relative to 5 of 12 rats housed in BH	30700
@VP	housed in BH	30734
@VP	using a one-tailed Fisher 's exact test	30759
@VP	revealed that this effect was significant -LRB- p = 0.003 -RRB-	30798
@VP	was significant -LRB- p = 0.003 -RRB-	30824
@VP	containing SCs in fibrin	30930
@VP	were studied -LRB- n = 3 -RRB-	31048
@VP	studied -LRB- n = 3 -RRB-	31053
@VP	grew into SC bridges and many bore peripheral myelin	31093
@VP	grew into SC bridges	31093
@VP	many bore peripheral myelin	31118
@VP	taken from a rat housed in MEH at 12 weeks after transplantation	31190
@VP	housed in MEH at 12 weeks after transplantation	31207
@VP	shows peripherally myelinated axons at higher magnification	31268
@VP	peripherally myelinated axons at higher magnification	31274
@VP	contained up to 13,279 SC-myelinated axons and up to 273 blood vessel profiles	31336
@VP	to examine whether axons grew longitudinally through grafts	31646
@VP	examine whether axons grew longitudinally through grafts	31649
@VP	grew longitudinally through grafts	31671
@VP	seen in previous studies from this laboratory -LSB- 13,27 -RSB-	31814
@VP	has not yet been elucidated	32060
@VP	been elucidated	32072
@VP	elucidated	32077
@VP	label the central branch of sensory axons from the right hindlimb sciatic nerve	32111
@VP	was injected three days prior to the end of the experiment	32223
@VP	injected three days prior to the end of the experiment	32227
@VP	ascending within the dorsal columns	32317
@VP	were completely interrupted by transection	32353
@VP	interrupted by transection	32369
@VP	had died back approximately 1 mm	32427
@VP	died back approximately 1 mm	32431
@VP	housed in BH or MEH	32584
@VP	were present in spinal cord rostral to sites of transection/transplantation	32648
@VP	housed in BH or MEH	32830
@VP	taken from an OEG/BH rat	32872
@VP	depicts serotonergic axons in spinal cord rostral to the site of transection	32898
@VP	did not regenerate beyond the site of transection	33013
@VP	regenerate beyond the site of transection	33021
@VP	taken from another OEG/BH rat , from an equivalent field of view	33077
@VP	shows that serotonergic axons did not grow beyond the site of transection	33142
@VP	did not grow beyond the site of transection	33172
@VP	grow beyond the site of transection	33180
@VP	suggesting that many SCs migrated into the injury site from the PNS	33480
@VP	migrated into the injury site from the PNS	33505
@VP	not shown	33554
@VP	not shown	33707
@VP	4	33720
@VP	afforded them many and varied opportunities for motor selfrehabilitation	33772
@VP	afforded them many	33772
@VP	varied opportunities for motor selfrehabilitation	33795
@VP	were predominantly sedentary	33870
@VP	assessed using BBB tests between one	33951
@VP	using BBB tests between one	33960
@VP	were detected both for OEG-transplanted rats and for SC/OEGtransplanted rats	34065
@VP	detected both for OEG-transplanted rats and for SC/OEGtransplanted rats	34070
@VP	were observed in all groups , whether maintained in BH or MEH	34199
@VP	observed in all groups , whether maintained in BH or MEH	34204
@VP	maintained in BH or MEH	34236
@VP	attained mean hindlimb scores above eight	34616
@VP	obtained peak mean hindlimb scores of nine and one OEG/MEH rat obtained 10.5	34694
@VP	obtained 10.5	34757
@VP	obtained a score of nine or more from three to 22 weeks post-surgery	34819
@VP	supported dorsal stepping	35216
@VP	stepping	35233
@VP	stepping	35257
@VP	supported plantar steps with no forelimb-hindlimb coordination	35351
@VP	were sustained up to 22 weeks in the majority of MEH rats	35467
@VP	sustained up to 22 weeks in the majority of MEH rats	35472
@VP	deteriorated to scores below 7	35602
@VP	became significant 14 weeks postsurgery in SC/OEG/BH rats	35854
@VP	using significance levels adjusted using Bonferroni 's correction	35978
@VP	adjusted using Bonferroni 's correction	36004
@VP	using Bonferroni 's correction	36013
@VP	transplanted with OEG by repeated ANOVA but not by numerous post hoc tests	36101
@VP	repeated ANOVA	36126
@VP	adjusted for multiple testing	36201
@VP	may relate to differences in statistical power	36231
@VP	relate to differences in statistical power	36235
@VP	were 7 rats in BH and 10 rats in MEH	36311
@VP	were only 5 rats in BH and 7 in MEH	36378
@VP	's in the OEG groups	36425
@VP	can be seen in Figures 3 -LRB- B -RRB- and 3 -LRB- C -RRB- respectively	36612
@VP	be seen in Figures 3 -LRB- B -RRB- and 3 -LRB- C -RRB- respectively	36616
@VP	seen in Figures 3 -LRB- B -RRB- and 3 -LRB- C -RRB- respectively	36619
@VP	completing this study	36710
@VP	detected in SC/OEG/BH rats	36876
@VP	involved in hindlimb function -LSB- 28 -RSB-	37263
@VP	were approximately one year old when the experiment was concluded	37337
@VP	was concluded	37389
@VP	concluded	37393
@VP	was probably not a factor in causing the progressive decline	37415
@VP	causing the progressive decline	37444
@VP	housed in BH	37494
@VP	housed in MEH	37518
@VP	exhibited crawling	37532
@VP	crawling	37542
@VP	alternating	37599
@VP	being supported on the knees rather than paws	37682
@VP	supported on the knees rather than paws	37688
@VP	do not see this behaviour in non-transplanted rats with transected spinal cords	38039
@VP	see this behaviour in non-transplanted rats with transected spinal cords	38046
@VP	transected spinal cords	38095
@VP	obtained by many of the OEG and SC/OEG rats in the present study	38148
@VP	are similar to	38213
@VP	using thoracic complete transection as an injury model	38275
@VP	remains the exception	39209
@VP	was not conducted	39409
@VP	conducted	39417
@VP	-LSB- 33 -RSB-	39524
@VP	stepping in adults rats with complete transection injury	39633
@VP	were not included in the present study because experience in our laboratory	39717
@VP	included in the present study because experience in our laboratory	39726
@VP	following moderate thoracic contusion -LSB- 1 -RSB-	40310
@VP	would provide significant improvement to transected rats without grafts	40398
@VP	provide significant improvement to transected rats without grafts	40404
@VP	are based on comparisons between BH and MEH	40519
@VP	based on comparisons between BH and MEH	40523
@VP	housed rats	40563
@VP	reported in these studies -LRB- up to a BBB of 10.5 -RRB-	40900
@VP	may differ from that of other groups	41058
@VP	differ from that of other groups	41062
@VP	has been reported using OEG prepared in our laboratory -LSB- 19 -RSB-	41140
@VP	been reported using OEG prepared in our laboratory -LSB- 19 -RSB-	41144
@VP	reported using OEG prepared in our laboratory -LSB- 19 -RSB-	41149
@VP	using OEG prepared in our laboratory -LSB- 19 -RSB-	41158
@VP	prepared in our laboratory -LSB- 19 -RSB-	41168
@VP	were slightly more caudal than in previous studies	41245
@VP	was spared -LSB- 17 -RSB-	41371
@VP	spared -LSB- 17 -RSB-	41375
@VP	was cut in our transection / OEG rats	41401
@VP	cut in our transection / OEG rats	41405
@VP	grafted SCs within fibrin rather than Matrigel -LSB- 14,19 -RSB-	41462
@VP	enclosed grafts	41614
@VP	re-entered the spinal cord caudal to the channel/SC transplant	41818
@VP	ascending central branches of sensory axons from L3-L6 DRG	41928
@VP	lie in L3-L6 DRG	42118
@VP	would be traced by the CTB injection	42139
@VP	be traced by the CTB injection	42145
@VP	traced by the CTB injection	42148
@VP	extend axons into SC bridges placed at T8-T10 one month previously	42177
@VP	placed at T8-T10 one month previously	42206
@VP	must explain the recovery of hindlimb movements in BH and MEH rats	42357
@VP	explain the recovery of hindlimb movements in BH and MEH rats	42362
@VP	examined in the present study -LRB- e.g. reticulospinal axons -RRB-	42475
@VP	regenerated across the site of transection and reinnervated distal cord	42533
@VP	regenerated across the site of transection	42533
@VP	reinnervated distal cord	42580
@VP	descending or ascending fiber tracts -LSB- 28,36 -RSB-	43137
@VP	are neuroprotective -LSB- 15 -RSB- and factors secreted by grafts	43207
@VP	secreted by grafts	43244
@VP	recovered in BH and MEH rats	43420
@VP	sustained in MEH rats due to regenerated axons	43453
@VP	being maintained/reinforced through sensory stimulation during motor activity	43531
@VP	maintained/reinforced through sensory stimulation during motor activity	43537
@VP	shows that housing rats in stimulating environments confers a number of benefits	43620
@VP	stimulating environments	43647
@VP	confers a number of benefits	43672
@VP	should arguably replace `` basic housing ''	43906
@VP	arguably replace `` basic housing ''	43913
@VP	depriving rats of social contact with other rats	43982
@VP	leads to physiological and behavioral abnormalities -LSB- 39 -RSB-	44031
@VP	hinder recovery after brain injury -LSB- 40,41 -RSB-	44151
@VP	change gait characteristics in intact rats -LSB- 42 -RSB-	44198
@VP	was recovered in rats housed in BH comparable to that recovered by rats in MEH	44304
@VP	recovered in rats housed in BH comparable to that recovered by rats in MEH	44308
@VP	housed in BH	44326
@VP	recovered by rats in MEH	44358
@VP	led to reduced BBB scores	44404
@VP	concerning functional recovery after injury	44621
@VP	emphasizing the need to monitor recovery for more than just one or two months	44810
@VP	to monitor recovery for more than just one or two months	44831
@VP	monitor recovery for more than just one or two months	44834
@VP	support the notion that recovery of function is enhanced by locomotor activity	45228
@VP	is enhanced by locomotor activity	45273
@VP	enhanced by locomotor activity	45276
@VP	can prevent progressive loss of restored hindlimb movement	45596
@VP	prevent progressive loss of restored hindlimb movement	45600
@VP	work	45975
@VP	will provide significant benefit in humans	46094
@VP	provide significant benefit in humans	46099
@VP	injured persons	46191
@VP	improving overall health and maintaining or improving residual function	46272
@VP	improving overall health	46272
@VP	maintaining or improving residual function	46301
